Articles
The reading room of Bioprocess Hub — a curated, continuously refreshed digest of the writing that matters across the bio-economy.
Every day we pull the latest long-form pieces from the sector's most respected blogs, trade journals and research outlets — Labiotech, Genetic Engineering News, Fierce Biotech, Fierce Pharma, Endpoints News, AgFunderNews, Green Queen, New Hope, ScienceDaily and the Good Food Institute — and distil each into a short, honest preview so you can decide what deserves your time. Coverage spans the full breadth of modern biomanufacturing: therapeutics and gene editing, cell and gene therapy, precision fermentation and alternative proteins, agricultural biologicals, the microbiome, upstream and downstream processing, and the funding rounds and national policies shaping where the industry goes next.
Nothing is paywalled or rewritten — every card links straight back to the original article at its source, giving those publishers full credit and you the complete story. Use the search box to track a topic — CAR-T, single-use bioreactors, India's BioE3 — or narrow the feed by sector, or by the country a story concerns. The filters build themselves from whatever is currently in the feed, so they always reflect the latest reading. It is the fastest way to stay fluent in an industry that moves quickly — check back often, because the collection grows every single day.
Upstream vs. Downstream Bioprocessing: The Big Picture
By Bioprocess Hub Admin · 8/21/2026
‘Bring us your difficult trait problems’: Biographica, Hudson River partner on crop genome editing
AgFunderNews · 9/21/2026Read original →
‘One of the fastest-growing CPG brands in America…’ David Protein owner hits $2.25bn valuation on $250m Series B
AgFunderNews · 9/4/2026Read original →
🎥 ‘The whole system is now more investable’: Reservoir makes the case for ag robotics
AgFunderNews · 8/29/2026Read original →
🎥 Atmonia scales green ammonia with single-step electrochemical process
AgFunderNews · 10/2/2026Read original →
🎥 Carbon Robotics: $100m+ revenue, new machine and a path to IPO
AgFunderNews · 8/31/2026Read original →
🎥 ClimateCrop bets on starch ‘off switch’ to improve crop performance
AgFunderNews · 10/13/2026Read original →
🎥 Eclipse Ingredients scales human lactoferrin platform: ‘We’re executing at a speed that is unheard of in this space’
AgFunderNews · 9/28/2026Read original →
🎥 From 2D images to 3D worlds: Bonsai bets on AI-powered farm robotics
AgFunderNews · 8/31/2026Read original →
🎥 Meatly bets on 20,000-liter scale to prove cultivated meat economics
AgFunderNews · 9/28/2026Read original →
🎥 Orchard Robotics CEO: Growers ‘shouldn’t have to be data analysts’
AgFunderNews · 9/2/2026Read original →
🎥 Resurrect Bio reawakens plants’ natural defenses: ‘It’s very targeted, almost like personalized medicine’
AgFunderNews · 10/5/2026Read original →
🎥 SenseUP aims to take RNAi pesticides from niche to mainstream
AgFunderNews · 10/16/2026Read original →
🎥 TRIC Robotics scales to 1,500 strawberry acres with 15-robot fleet
AgFunderNews · 9/1/2026Read original →
🎥 Verley scales BLG to 200,000-L as precision fermentation enters its prove-it phase
AgFunderNews · 10/6/2026Read original →
🎥 What is agrihealth—and can it become an investable category? The First Thirty makes the case
AgFunderNews · 9/25/2026Read original →
🎥 Where are foodtech investors looking next after the boom and bust?
AgFunderNews · 10/7/2026Read original →
🎥Agrifood VC needs a different playbook, says Pymwymic: “Corporate venture capital needs to step in earlier”
AgFunderNews · 9/24/2026Read original →
AgriFood Signals: Confido raises $55m to help CPGs, Tesco backs Henry Dimbleby’s fund, UPF food labeling
AgFunderNews · 9/25/2026Read original →
AgriFood Signals: Corteva & Inari settle, Starbucks scales back green goals, countries rethink climate reporting
AgFunderNews · 10/2/2026Read original →
AgriFood Signals: Edonia raises funds to scale spirulina protein, AI agents for restaurants, PepsiCo does VR
AgFunderNews · 10/9/2026Read original →
AgriFood Signals: EIF backs Nordic Foodtech VC, NotCo sells Brazilian business, Agronutris in receivership
AgFunderNews · 9/11/2026Read original →
AgriFood Signals: Farmbot unearths fresh funding, Homestead Capital nabs $150m, Gates backs ‘HeatSmart’ cassava
AgFunderNews · 8/21/2026Read original →
AgriFood Signals: India’s Scimplify nets $25m, Deere funds food security, USDA funds seed research
AgFunderNews · 10/15/2026Read original →
AgriFood Signals: Remembering Wendell Berry, Farmland LP’s new fund, Dairy Queen robots
AgFunderNews · 9/3/2026Read original →
AgriFood Signals: Reservoir & Deere partnership, 80 Acres Farms lawsuit, new blended finance for Africa
AgFunderNews · 8/28/2026Read original →
AgriFood Signals: Syngenta HK IPO, Terradot and Google do enhanced rock weathering, Corteva split lawsuits
AgFunderNews · 9/18/2026Read original →
Antobot scales UV-C robotics push with 300 deployments targeted in 2027
AgFunderNews · 10/1/2026Read original →
Austrian alt meat startup Revo Foods targets profitability by Q3 2027 as 3D-printing scales up
AgFunderNews · 10/1/2026Read original →
BREAKING: The EVERY Co prevails in legal spat with Onego Bio
AgFunderNews · 10/12/2026Read original →
BREAKING: UPSIDE Foods terminates $50m bid for Believer Meats’ US site but “remains interested in the facility”
AgFunderNews · 8/24/2026Read original →
Builders VC and others back SweetAg’s bid to modernize the agricultural lending process
AgFunderNews · 9/7/2026Read original →
Can Culta take Japan’s premium fruit model global?
AgFunderNews · 9/14/2026Read original →
Can smarter surveillance help poultry farms catch bird flu earlier?
AgFunderNews · 8/25/2026Read original →
Century-old Keystone Cooperative joins Alloy Partners’ venture studio for animal, human and planetary health
AgFunderNews · 8/24/2026Read original →
Could GLP-1 drugs finally put a price on crop nutrient density?
AgFunderNews · 10/8/2026Read original →
CropX acquires NIR spectroscopy firm SCIO in biggest deal yet, eyes profitability in 2027
AgFunderNews · 8/26/2026Read original →
Digital ag platform xFarm Technologies expands to sugarcane, biofuels with Sibium Analytics acquisition
AgFunderNews · 9/15/2026Read original →
EU looks to speed agricultural research to market despite budget pressures
AgFunderNews · 10/2/2026Read original →
Exclusive: ArkeaBio raises $15m for livestock methane tech, cuts headcount
AgFunderNews · 9/30/2026Read original →
Exclusive: Ayana Bio acquires Meati Foods assets for a steal to scale plant cell culture tech with Zenfold in India
AgFunderNews · 9/15/2026Read original →
Exclusive: Believer Meats creditors weigh bid for US plant after UPSIDE Foods exit
AgFunderNews · 9/30/2026Read original →
Exclusive: FOOD FOUNDERS Studio secures new funding to build its next two foodtech ventures
AgFunderNews · 9/30/2026Read original →
Exclusive: Lilac Agriculture raises $2.3m to tackle inoculants’ ‘black box’ problem
AgFunderNews · 9/22/2026Read original →
Exclusive: Plantd converts a construction waste problem into revenue with new biochar line
AgFunderNews · 8/28/2026Read original →
Exclusive: Plantik and Hudson River Biotechnology team up to de-risk heat-tolerant strawberries
AgFunderNews · 9/28/2026Read original →
Exclusive: Yara Growth Ventures backs soil-sensing startup Stenon as fertilizer prices surge
AgFunderNews · 10/12/2026Read original →
Facet Amtech bets on multifunctional catalyst to disrupt ammonia production
AgFunderNews · 8/26/2026Read original →
FBN and Google team up to give farm AI the context it’s been missing
AgFunderNews · 10/1/2026Read original →
Formo scales precision-fermented casein ahead of US debut as narrative shifts from sustainability and ethics to performance
AgFunderNews · 9/16/2026Read original →
Guest article: There’s a market for saline agriculture. It just needs a boost
AgFunderNews · 9/25/2026Read original →
Guest article: When nutrition becomes an evidence-based intervention, capital follows
AgFunderNews · 9/29/2026Read original →
How AgFunder is using AI to build a venture firm that remembers
AgFunderNews · 9/11/2026Read original →
IIF to launch its farm investment platform across Canada following new capital raise from Verdex
AgFunderNews · 8/20/2026Read original →
Impossible Foods makes UK retail debut at Tesco… without its flagship heme protein
AgFunderNews · 9/23/2026Read original →
In ovo sexing hits 40% penetration in the EU. What will it take to crack the US?
AgFunderNews · 9/9/2026Read original →
It will take more than data to improve traceability in the cotton supply chain
AgFunderNews · 10/20/2026Read original →
It’s time to take action on cybersecurity in agrifood
AgFunderNews · 10/13/2026Read original →
Knip bets on postbiotics, not commodity protein, as it scales biomass fermentation
AgFunderNews · 9/10/2026Read original →
Kodama nets $7m to scale physical AI for ‘intelligent forestry’
AgFunderNews · 10/19/2026Read original →
Livestock management app Breedr plans expansion after $27m raise led by Partech’s impact arm
AgFunderNews · 8/27/2026Read original →
Mafix raises $5.4m to activate silicate rock into climate-smart fertilizer
AgFunderNews · 8/20/2026Read original →
MOA Foodtech nets $3.8m to scale AI-powered biomass fermentation platform
AgFunderNews · 9/3/2026Read original →
Molagri raises $5.8m to build ‘updatable’ biopesticides
AgFunderNews · 10/14/2026Read original →
Myca raises $1.3m pre-seed to put AI agents in charge of agribusiness field operations
AgFunderNews · 10/7/2026Read original →
Natural Capital gaining ‘increasing recognition’ from more institutional investors: report
AgFunderNews · 8/21/2026Read original →
No, imaging won’t help farmers control plant disease
AgFunderNews · 9/11/2026Read original →
NoFence’s new herd management platform points to virtual fencing’s next chapter
AgFunderNews · 9/8/2026Read original →
OlsAro raises $5.5m seed round as salt-tolerant wheat nears market
AgFunderNews · 10/14/2026Read original →
Orbit Ventures on innovation theater, AI to turbocharge emerging markets, and the risks of Blitzscaling
AgFunderNews · 9/4/2026Read original →
PerPlant lands Valtra deal to put its AI crop sensor on tractors straight from the factory
AgFunderNews · 10/14/2026Read original →
PhytoFoundry emerges from stealth with plant cell culture platform targeting high value bioactives
AgFunderNews · 9/17/2026Read original →
ProducePay eyes profitability as it shifts from capital to data: ‘We think 2027 will be a breakout year’
AgFunderNews · 9/10/2026Read original →
Regen-organic food can be ‘measurably more nutritious,’ says new research from Edacious and ROA
AgFunderNews · 10/8/2026Read original →
Robigo Bio eyes commercialization for its ag biologicals with Leaps by Bayer investment
AgFunderNews · 9/17/2026Read original →
SLM Partners secures $167m from Dutch pension investor to regenerate forests
AgFunderNews · 10/13/2026Read original →
Sound Agriculture launches seed-applied biological to preserve yields on high ammonium corn acres
AgFunderNews · 9/24/2026Read original →
Switch Bio partners with Bayer to advance ‘switchable’ tech for biofertilizers
AgFunderNews · 10/13/2026Read original →
TerraBlaster raises $12.5m for real time NPK soil mapping at tractor speed
AgFunderNews · 8/25/2026Read original →
The Mixing Bowl says it’s still ‘early days’ for crop robotics but AI, M&A are driving advancement
AgFunderNews · 9/24/2026Read original →
These constraints are holding agrifood back. AgFunder is investing to solve them
AgFunderNews · 9/18/2026Read original →
Twiga’s demise underscores the need for new financing models in African agrifoodtech
AgFunderNews · 10/7/2026Read original →
UK Agri-Tech Centre to slash workforce by 60% in strategic pivot to new operating model
AgFunderNews · 10/16/2026Read original →
US spray drone market “very much in flux” as firms attempt to navigate evolving landscape, says ASDC
AgFunderNews · 10/9/2026Read original →
Virtual fencing is no longer hype. Now it has to prove itself a trustworthy tool
AgFunderNews · 9/23/2026Read original →
With young farmers struggling, PepsiCo explores ways to keep agriculture ‘a viable and attractive livelihood’
AgFunderNews · 9/2/2026Read original →
xFarm Technologies’ acquisition of Sibium Analytics brings it closer to defining agriculture’s data layer
AgFunderNews · 9/21/2026Read original →
#EASD26: Lilly's triple-G allows 60% of patients to drop below obesity threshold
Endpoints News · 9/30/2026Read original →
#EASD26: Regeneron's antibody helps patients regain muscle after stopping GLP-1 therapy
Endpoints News · 10/1/2026Read original →
#EASD26: Zealand and Roche's amylin works best at middle dose, trails Lilly's
Endpoints News · 9/30/2026Read original →
#ESC26: Arrowhead claims safety edge over Ionis as triglyceride battle draws closer
Endpoints News · 8/30/2026Read original →
#ESC26: AstraZeneca's relaxin pill shows promise in mid-stage heart failure trial
Endpoints News · 8/30/2026Read original →
#ESC26: CRISPR Therapeutics to pursue highest dose of its lipid lowering gene editing therapy
Endpoints News · 8/28/2026Read original →
#ESC26: Novartis pushes ahead with its IL-6 inhibitor despite Novo's failure
Endpoints News · 8/29/2026Read original →
#ESMO26 regular abstracts featuring Zai Lab, GSK, Merck and more
Endpoints News · 10/19/2026Read original →
A search for ‘the statin of Alzheimer’s’; Arrowhead injectable lowers tau; and more
Endpoints News · 10/17/2026Read original →
AbbVie claims Phase 3 win for multiple myeloma drug etentamig
Endpoints News · 9/3/2026Read original →
AbbVie-allied ADARx aims for IPO with 3 drugs in the clinic
Endpoints News · 9/5/2026Read original →
AbbVie's next-gen dopamine therapy for Parkinson's gets FDA approval
Endpoints News · 9/26/2026Read original →
Acting general counsel at HHS has left the department
Endpoints News · 10/9/2026Read original →
Adicet Bio shares promising look at CAR-T for lupus, but stock drops anyway
Endpoints News · 9/29/2026Read original →
Akeso details survival win for its PD-1xVEGF drug versus Keytruda
Endpoints News · 9/13/2026Read original →
All 50 states sign up for most favored nation prices under Medicaid, Trump says
Endpoints News · 9/19/2026Read original →
Alzheon outlines plans for major fundraising round despite Phase 3 miss for Alzheimer's drug
Endpoints News · 9/11/2026Read original →
Amgen, academic centers weigh new FDA pilot to speed early drug trials
Endpoints News · 8/26/2026Read original →
Amgen’s T-cell engager notches major new lung cancer victory
Endpoints News · 9/8/2026Read original →
Another Novartis failure; Novo drops the ‘Nordisk’; and more
Endpoints News · 9/19/2026Read original →
Antheia gets $80M conditional DOD loan to onshore to the US
Endpoints News · 10/20/2026Read original →
ARPA-H awards $125M for manufacturing custom RNA therapies on demand
Endpoints News · 9/2/2026Read original →
ARPA-H picks UpDoc, Tempus and Atman to build AI tools for heart disease
Endpoints News · 9/9/2026Read original →
ArriVent's lung cancer drug firmonertinib fails key late-stage trial, stock tanks
Endpoints News · 10/6/2026Read original →
Arsenal Biosciences cuts ‘majority’ of staff in move to in vivo CAR-T
Endpoints News · 9/1/2026Read original →As Trump 2.0 targets federal research, a new study shows the stakes
Endpoints News · 8/21/2026Read original →
Asahi Kasei lands approval for new HSV treatment
Endpoints News · 10/12/2026Read original →
AstraZeneca blames trial design for Phase 3 failure of bone disease drug
Endpoints News · 10/12/2026Read original →
AstraZeneca buys a $2B stake in Summit, taking equity in bet on cancer drug
Endpoints News · 9/29/2026Read original →
AstraZeneca does AI deal with insitro; inVIOs' Phase 1 success in solid tumors
Endpoints News · 10/15/2026Read original →
AstraZeneca heralds new R&D facility in that ‘other’ Cambridge
Endpoints News · 10/6/2026Read original →
Baby KJ's gene-editing drug cost $1.65M to make, Fyodor Urnov says
Endpoints News · 9/23/2026Read original →
Bausch + Lomb plans Phase 3 trial for dry eye drop, despite missing mid-stage goal
Endpoints News · 8/25/2026Read original →
Bayer unpacks plans for $2.2B manufacturing site in Ohio
Endpoints News · 10/3/2026Read original →
Beam sues YolTech and Serapha Bio for allegedly stealing its gene editing tech
Endpoints News · 9/30/2026Read original →
Biohaven strikes $795M deal for commercial partner in epilepsy
Endpoints News · 8/26/2026Read original →
BioNTech says CTLA-4 drug nearly doubled survival times for lung cancer
Endpoints News · 9/14/2026Read original →
BioNTech, Genentech terminate Phase 2 of personalized mRNA cancer vaccine
Endpoints News · 8/28/2026Read original →
Bristol Myers reveals a pair of Phase 3 wins for fibrosis, RayzeBio drugs
Endpoints News · 10/12/2026Read original →
Bristol Myers scraps $100M Orum-partnered cancer drug
Endpoints News · 9/18/2026Read original →
CAR-T deaths prompt halt by Novartis; Eli Lilly’s 13th acquisition of 2026; and more
Endpoints News · 9/5/2026Read original →
CBER official overruled review team's rejection of new Replimune melanoma drug
Endpoints News · 9/2/2026Read original →
CDC page supporting Covid vaccines for pregnancy went dark
Endpoints News · 10/16/2026Read original →
Cellares rebukes Bristol Myers' criticism of its cell therapy technology
Endpoints News · 8/26/2026Read original →
Centric Compounding recalls three injectables over contamination
Endpoints News · 9/15/2026Read original →
China pursues export ban on some biotech platforms
Endpoints News · 10/16/2026Read original →
Chinese vaccine scandal leads to life sentence; Flagship wins defense contract
Endpoints News · 9/23/2026Read original →
CHMP backs Novo’s hemophilia A drug and seven other medicines
Endpoints News · 9/18/2026Read original →
Chronic pain biotech co-founded by Vivek Ramaswamy joins reverse merger train
Endpoints News · 8/21/2026Read original →
Claret says its latest fund will have larger focus on European life sciences
Endpoints News · 9/7/2026Read original →
CMS finalizes GLOBE Medicare demo but savings trail projections
Endpoints News · 10/1/2026Read original →
Compounder Empower receives FDA warning letter over GLP-1s
Endpoints News · 9/23/2026Read original →
Curium prices generic radioligand at 5% discount to Novartis' Lutathera
Endpoints News · 10/9/2026Read original →
Current heads of CBER, CDER snag permanent jobs
Endpoints News · 9/9/2026Read original →
DC judge rejects Merck’s IRA case more than three years after it was filed
Endpoints News · 8/24/2026Read original →
Drugmakers cooperate with House probe of China trial sites
Endpoints News · 9/17/2026Read original →
Dutch court blocks subcutaneous Keytruda in eight European countries
Endpoints News · 10/7/2026Read original →
Elevar wins first FDA approval with second-line drug for bile duct cancer
Endpoints News · 9/24/2026Read original →
Eli Lilly’s best-ever weight loss data; Sanofi, Regeneron re-up for $1B upfront; and more
Endpoints News · 10/3/2026Read original →
Encoded closes $275M Series F for Dravet syndrome drug
Endpoints News · 9/9/2026Read original →
Enveda raises its third megaround for I&I and weight maintenance drug candidates
Endpoints News · 9/23/2026Read original →
FDA adcomm votes in favor of benefit-risk of Grail’s cancer test
Endpoints News · 9/23/2026Read original →
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
Endpoints News · 9/7/2026Read original →
FDA approves ataxia-telangiectasia drug; Alkermes reports ADHD data
Endpoints News · 9/21/2026Read original →
FDA approves Eli Lilly's once-weekly insulin pen, setting up rivalry with Novo
Endpoints News · 9/24/2026Read original →
FDA approves first radioligand generic, setting up rivalry with Novartis
Endpoints News · 9/15/2026Read original →
FDA approves Jazz's Ziihera in frontline gastric cancer
Endpoints News · 8/25/2026Read original →
FDA approves Lilly's oral SERD combo for second-line breast cancer therapy
Endpoints News · 9/19/2026Read original →
FDA approves Mirum’s drug for ultra-rare soft tissue disease
Endpoints News · 9/26/2026Read original →
FDA approves Takeda, Protagonist drug for rare blood disorder
Endpoints News · 8/29/2026Read original →
FDA approves Ultragenyx's gene therapy for Sanfilippo syndrome type A
Endpoints News · 9/18/2026Read original →
FDA considers interim access for compounded peptides; Enspryng's label expansion
Endpoints News · 10/16/2026Read original →
FDA delays Capricor's deramiocel PDUFA date to review new data
Endpoints News · 8/24/2026Read original →
FDA delays Novo’s hemophilia A drug review over factory issues
Endpoints News · 10/5/2026Read original →
FDA extends review of Exelixis' colorectal cancer drug candidate
Endpoints News · 9/11/2026Read original →
FDA faces questions on 'America First' provisions in latest user fee agreement
Endpoints News · 9/16/2026Read original →
FDA grapples with China biotech's rise across the agency
Endpoints News · 9/17/2026Read original →
FDA leaders project enhanced scrutiny of foreign data
Endpoints News · 9/3/2026Read original →
FDA looks into reassessing criteria around rare disease trials, endpoint selection
Endpoints News · 9/14/2026Read original →
FDA offers little comment on Grail cancer test ahead of adcomm
Endpoints News · 9/21/2026Read original →
FDA opens clinical trial modernization office in CDER
Endpoints News · 10/2/2026Read original →
FDA should follow EMA's lead on drug rejection disclosures, researchers say
Endpoints News · 9/9/2026Read original →
FDA suggests regulatory flexibility for assessing psychedelics
Endpoints News · 9/10/2026Read original →
Former MIT professor David Sabatini awarded $6M in defamation case
Endpoints News · 10/20/2026Read original →
FTC accuses Martin Shkreli of violating lifetime pharma ban
Endpoints News · 10/14/2026Read original →
Genentech AI leader Richard Bonneau leaves pharma in latest exit
Endpoints News · 10/6/2026Read original →
Genentech invests $750M in new factory; Bavarian Nordic delays Lyme trial
Endpoints News · 8/21/2026Read original →
Geographic atrophy biotech Aviceda to shut down after Phase 2 fail
Endpoints News · 10/3/2026Read original →
Gilead gets another HIV treatment approval, extending lenacapavir's dominance
Endpoints News · 8/28/2026Read original →
Gilead reaches HIV PrEP agreements; Hong Kong investigates Cloudbreak IPO
Endpoints News · 9/16/2026Read original →
Gilead’s pill posts stronger colitis remission rates than Entyvio
Endpoints News · 10/19/2026Read original →
GSK heads to FDA with recently acquired drug from Nuvalent
Endpoints News · 9/14/2026Read original →GSK to wind down German vaccine factory due to lack of demand
Endpoints News · 9/14/2026Read original →
Haisco grants license to Sentivera; ViiV's HIV treatment OK'd for newborns
Endpoints News · 8/26/2026Read original →
Health Tech meets AI giants
Endpoints News · 9/2/2026Read original →
How past Endpoints 11 winners fared as biotech industry rebounded
Endpoints News · 9/10/2026Read original →
Impacts of CMS’ GLP-1 pilot program begin to take shape
Endpoints News · 8/28/2026Read original →
In DC, a secretive new thorn has appeared in pharma's side
Endpoints News · 10/7/2026Read original →
Internal CMS email confirms Globe and Guard exemption plan
Endpoints News · 9/18/2026Read original →
Ionis wins FDA approval of Alexander disease drug zilganersen
Endpoints News · 9/4/2026Read original →
Is AI jacking up healthcare costs?
Endpoints News · 10/1/2026Read original →
J&J’s Imaavy wins label expansion; Two approvals in Japan
Endpoints News · 8/25/2026Read original →
Jury awards Nektar $90M in suit against Lilly
Endpoints News · 9/25/2026Read original →
Key research behind orexin and narcolepsy wins Lasker Award
Endpoints News · 9/9/2026Read original →
Klomp, Warren spar over MFN deal contracts
Endpoints News · 9/16/2026Read original →
Landmark approval for pancreatic cancer; Reactions to Lilly’s Phase 1 secrecy; and more
Endpoints News · 8/29/2026Read original →
Lilly pulls back from Foghorn's synthetic lethality work as biotech sheds 40% of staff
Endpoints News · 10/1/2026Read original →
Lilly signals move into aesthetics, looking to add products for body, skin and hair
Endpoints News · 10/2/2026Read original →
Lilly to buy TED startup Merida Biosciences in its 13th acquisition of 2026
Endpoints News · 8/31/2026Read original →
Lonza to build new US factory; Samsung Bio signs $262M contract
Endpoints News · 9/10/2026Read original →
MassBio report details challenges spanning China, NIH
Endpoints News · 8/26/2026Read original →
Merck reports mixed data for Lucentis competitor in diabetic macular edema
Endpoints News · 10/12/2026Read original →
Merck's top dealmaker signals more M&A as Keytruda's patent cliff nears
Endpoints News · 9/4/2026Read original →
Mirum reports Phase 3 victory for acquired hepatitis D med
Endpoints News · 9/29/2026Read original →
Mirum succeeds in rare liver disease trial; First Tracks delivers in celiac
Endpoints News · 10/12/2026Read original →
Mounjaro scores FDA approval to reduce CV risk; Teva to buy an approved drug
Endpoints News · 8/28/2026Read original →
New biotech alliance tells Congress to fight for US dominance
Endpoints News · 9/30/2026Read original →
New data on RevMed’s Rasonque leave potential opening for other treatments
Endpoints News · 10/9/2026Read original →
New FDA framework tilts toward consistency over flexibility
Endpoints News · 10/14/2026Read original →
New PDUFA deal sets aside FDA money to rehire reviewers
Endpoints News · 10/9/2026Read original →
New report may spell trouble for future cheaper biologics
Endpoints News · 9/11/2026Read original →
NorthStar's China CRO deal; Lonza details midterm guidance
Endpoints News · 10/15/2026Read original →
Novartis CAR-T deaths raise questions over acceptable autoimmune risk
Endpoints News · 9/3/2026Read original →
Novartis quietly returns a key antibiotic to US market
Endpoints News · 10/14/2026Read original →
Novartis scraps Fabhalta study in lupus nephritis
Endpoints News · 10/16/2026Read original →
Novartis' drug delivery deal with Alteogen; More worker cuts at Cellares
Endpoints News · 9/3/2026Read original →
Novartis' Phase 3 pelacarsen study miss raises the stakes for Amgen, Lilly
Endpoints News · 9/7/2026Read original →
Novo's CEO knows the drugmaker needs to build confidence
Endpoints News · 9/22/2026Read original →
Ono pays Biohaven $80M for protein degrader; UK pulls Valneva's chikungunya shot
Endpoints News · 10/8/2026Read original →
Parkinson's cell therapy biotech Aspen and I&I startup Bambusa file for IPOs
Endpoints News · 10/10/2026Read original →
Patient death raises liver questions ahead of Bristol Myers readout
Endpoints News · 10/1/2026Read original →
Pentagon defends designating WuXi AppTec as Chinese military company
Endpoints News · 9/22/2026Read original →
Pfizer shares ADC rights with Medicus; RevMed updates lung cancer data
Endpoints News · 9/3/2026Read original →
Pfizer, Lilly 'most favored nation' deals to give US share of raised foreign prices
Endpoints News · 9/21/2026Read original →
Pharma industry asks FDA for more details on when one trial is enough
Endpoints News · 9/25/2026Read original →
Pharma's legal battle over Medicare negotiations reaches 'dead end'
Endpoints News · 8/27/2026Read original →
Pharvaris' stock jumps on pivotal success in rare genetic disease
Endpoints News · 9/8/2026Read original →
PhRMA picks Eric Cantor as next chief
Endpoints News · 9/29/2026Read original →
PhRMA sues Trump administration over GLOBE drug pricing demo program
Endpoints News · 10/8/2026Read original →
Post-Hoc Live: The China Biotech Debate goes to Washington
Endpoints News · 9/18/2026Read original →
Q&A: Sanofi's new research chief on AI, R&D failure rates and dealmaking
Endpoints News · 10/16/2026Read original →
Regenxbio hit with another clinical hold for Hunter syndrome gene therapy
Endpoints News · 8/24/2026Read original →
Researchers implant human neurons in mice brains to study disease
Endpoints News · 9/16/2026Read original →
RFK Jr. takes another step toward dismantling vaccine recommendations
Endpoints News · 8/21/2026Read original →
Robotics company Multiply Labs nets $75M; Isotope maker NorthStar gets up to $185M
Endpoints News · 10/8/2026Read original →
Roche secures separate discovery deals with Atavistik, Earendil
Endpoints News · 9/24/2026Read original →
Roivant's dermatomyositis drug Lisraya snags FDA approval
Endpoints News · 8/28/2026Read original →
Sanofi-backed Electra files for IPO to fund Phase 2/3 immunology drug
Endpoints News · 8/31/2026Read original →
Sanofi's new R&D chief: Western pharma should rethink China's drug pipeline role
Endpoints News · 10/15/2026Read original →
Sarepta to pay Regenxbio $39M to settle gene therapy claims; Vida eyes fourth fund
Endpoints News · 9/24/2026Read original →
Senior Leerink analyst downgrades Bristol Myers, citing pipeline fears
Endpoints News · 10/6/2026Read original →
Setbacks for Novartis; Anthropic looks for a dealmaker; and more
Endpoints News · 9/12/2026Read original →
Shionogi's stroke drug fails mid-stage; Bayer's Hyrnuo gets expanded label
Endpoints News · 9/10/2026Read original →
Sionna cuts nearly half of staff as it lines up second attempt at cystic fibrosis
Endpoints News · 9/15/2026Read original →
Soufflé gets $135M for three RNA medicines
Endpoints News · 10/13/2026Read original →
Sword Health plans to buy Headspace, filing says
Endpoints News · 8/26/2026Read original →
Take the Q3 Biopharma Sentiment Survey (BPSI)
Endpoints News · 8/31/2026Read original →
The drug industry’s care gap; Novo aims to diversify; and more
Endpoints News · 9/26/2026Read original →
The race to make new Ebola vaccines faces a cash crunch
Endpoints News · 9/4/2026Read original →
Thiel-backed Lindus sells CRO arm in pivot to hunt for drug assets
Endpoints News · 9/4/2026Read original →
Third death in China’s expedited trials; Merck and Moderna’s cancer vaccine win; and more
Endpoints News · 8/22/2026Read original →
Three takeaways from Trump's latest drug pricing event
Endpoints News · 9/1/2026Read original →
To get drugmakers into ultra-rare disease, the answer isn’t rare disease at all
Endpoints News · 9/25/2026Read original →
Trump announces nine new MFN drug pricing deals
Endpoints News · 9/1/2026Read original →
UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy
Endpoints News · 9/2/2026Read original →
Ultragenyx sells PRV for $210M and still has another to monetize
Endpoints News · 10/7/2026Read original →
Ultragenyx's second PRV sale; Biomea's oral GLP-1 data leads to stock slump
Endpoints News · 10/14/2026Read original →
United Therapeutics' legal victory; BMS' Camzyos approved for kids
Endpoints News · 10/1/2026Read original →
Updated: Novo Nordisk cans 2 more trials of IL-6 heart drug for futility
Endpoints News · 9/7/2026Read original →
US investigates German drug prices as EU pharmas seek to compete
Endpoints News · 9/22/2026Read original →
US-China biotech NeuShen gets $80M to develop brain-health drugs
Endpoints News · 9/4/2026Read original →
Utah steps up AI prescribing
Endpoints News · 10/7/2026Read original →
Varda gets $251M to make medicines in space, a long-sought area for drugs
Endpoints News · 9/30/2026Read original →
Vaxcyte's pneumococcal vaccine succeeds in Phase 3, stock surges
Endpoints News · 10/5/2026Read original →
Verastem makes its stand as a RevMed competitor in pancreatic cancer
Endpoints News · 10/14/2026Read original →
Verdiva cans mid-stage obesity trial of GLP-1 pill, citing 'market evolution'
Endpoints News · 10/13/2026Read original →
Vertex aims for broad kidney disease label ahead of key readout next year
Endpoints News · 9/22/2026Read original →
Viatris to make $1.65B Pacira acquisition, adding to momentum in pain
Endpoints News · 10/8/2026Read original →
Virginia leads in winning investments as drugmakers onshore to the US
Endpoints News · 10/15/2026Read original →
White House takes stock of US-based manufacturing for 86 essential drugs
Endpoints News · 9/28/2026Read original →
Why apps want your medical records
Endpoints News · 9/8/2026Read original →
Women in Biopharma 2026; A secretive new thorn in pharma’s side; and more
Endpoints News · 10/10/2026Read original →
Yarrow brings in more cash; AbbVie drug succeeds in menstrual migraine trial
Endpoints News · 9/11/2026Read original →
Zuckerberg's Biohub expands virtual cell effort to $1.8B, with Meta, Google
Endpoints News · 10/7/2026Read original →‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing it
Fierce Biotech · 9/1/2026Read original →A year on from Big Pharma’s pull-back from the UK, has anything changed?
Fierce Biotech · 9/7/2026Read original →AbbVie-backed ADARx plans IPO to bankroll array of clinical-stage siRNA therapies
Fierce Biotech · 9/8/2026Read original →After one failed acquisition attempt, Lisata finds lifeline in Marea merger
Fierce Biotech · 9/18/2026Read original →Akeso CEO looks beyond lung cancer with biliary tract win, counters ivonescimab debate
Fierce Biotech · 8/27/2026Read original →Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win
Fierce Biotech · 9/23/2026Read original →ArsenalBio sheds most of staff in pivot to in vivo CAR-T
Fierce Biotech · 9/2/2026Read original →Artelo’s ex-AstraZeneca cannabinoid agonist holds its own against GLP-1 drug semaglutide in obese mice
Fierce Biotech · 9/21/2026Read original →AusperBio adds $120M series C to advance hep B oligo therapy through phase 3 and beyond
Fierce Biotech · 8/31/2026Read original →AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
Fierce Biotech · 9/9/2026Read original →Biohaven epilepsy drug suffers FDA hold days after attracting $350M deal
Fierce Biotech · 9/11/2026Read original →BioNTech-Genentech cancer vax records more deaths than control in scrapped ph. 2 test
Fierce Biotech · 8/31/2026Read original →Boehringer adds $250M to value of Variant pact by expanding into cardiovascular disease
Fierce Biotech · 9/24/2026Read original →Boehringer places phase 1 study of investigational drug on hold to examine ‘safety event’
Fierce Biotech · 8/24/2026Read original →Boston Scientific cyberattack likely to have ‘material impact’ on financial results
Fierce Biotech · 9/9/2026Read original →Celldex monoclonal antibody rebounds with pair of phase 3 wins for chronic skin condition
Fierce Biotech · 9/23/2026Read original →CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’
Fierce Biotech · 9/17/2026Read original →CEPI backs push to bring Egyptian biotech's Ebola vaccine into clinic to curb fast-growing outbreak
Fierce Biotech · 8/28/2026Read original →China targets 25% share of global first-in-class drugs in new 5-year plan
Fierce Biotech · 9/22/2026Read original →Chutes & Ladders—Invivyd's chairman adds CEO role ahead of COVID readout
Fierce Biotech · 9/5/2026Read original →Chutes & Ladders—Neumora shuffles leadership ahead of IND
Fierce Biotech · 8/24/2026Read original →Corbus posts phase 1 obesity data for drug mechanism that defeated Novo, Sanofi
Fierce Biotech · 9/15/2026Read original →DPHARM: How to address the clinical trial enrollment crisis?
Fierce Biotech · 9/18/2026Read original →Electra aims for $342M IPO to power inflammatory drug’s push through phase 3
Fierce Biotech · 9/15/2026Read original →Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push
Fierce Biotech · 9/1/2026Read original →Enveda reaps $311M series E to feed ambition to become a ‘household name’
Fierce Biotech · 9/24/2026Read original →ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM
Fierce Biotech · 9/2/2026Read original →FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer
Fierce Biotech · 9/9/2026Read original →FDA delays approval decision for Exelixis' tyrosine kinase inhibitor in colorectal cancer
Fierce Biotech · 9/14/2026Read original →FDA greenlights Revolution Medicines' pancreatic cancer gamechanger
Fierce Biotech · 8/27/2026Read original →FDA launches pilot program to speed up sluggish phase 1 trials
Fierce Biotech · 9/16/2026Read original →Fierce Biotech Fundraising Tracker '26: NeuShen nets $80M; Superluminal snags $60M
Fierce Biotech · 9/8/2026Read original →Fierce Biotech Layoff Tracker 2026: Novo reveals 4k more employees were laid off; Sionna halves staff
Fierce Biotech · 9/22/2026Read original →Fortrea boosts early-phase CRO platform with $45M acquisition of Worldwide division
Fierce Biotech · 9/3/2026Read original →Founded by Metsera backers, Sentivera emerges with $1.5B inflammatory disease deal
Fierce Biotech · 8/26/2026Read original →Frazier Life Sciences nets $1.1B in long-running fund aimed at small, midsize biotechs
Fierce Biotech · 9/11/2026Read original →GE HealthCare mulls $1B imaging chemicals maker deal: Financial Times
Fierce Biotech · 9/14/2026Read original →Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol
Fierce Biotech · 9/18/2026Read original →GSK’s Hansoh-partnered ADC lays down marker for lung cancer scrap with Merck
Fierce Biotech · 9/14/2026Read original →GV-backed Encoded gains $275M to advance Dravet drug, scale genetic med manufacturing
Fierce Biotech · 9/10/2026Read original →Immunovant ends cutaneous lupus program after phase 2 flop
Fierce Biotech · 9/24/2026Read original →Implantica finally nabs FDA approval 8 years after EU green light for reflux implant
Fierce Biotech · 8/26/2026Read original →Inside the growing world of biopharma prediction markets
Fierce Biotech · 9/21/2026Read original →Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
Fierce Biotech · 9/7/2026Read original →Is Moderna, Merck's mRNA cancer vaccine win the start of a 'personalized medicine revolution'?
Fierce Biotech · 9/13/2026Read original →J&J looking to offload orthopedics unit in $20B deal to Apollo: Bloomberg
Fierce Biotech · 9/15/2026Read original →JATT mastermind launches latest biotech-focused SPAC via $60M IPO
Fierce Biotech · 8/27/2026Read original →Kura creates Lilly-backed spinout armed with $50M to advance next-gen diabetes therapy
Fierce Biotech · 9/10/2026Read original →Labcorp launches new hepatitis D test to find patients with most severe form of virus
Fierce Biotech · 8/26/2026Read original →Lilly cans early experimental obesity drug after ‘high bar’ not met
Fierce Biotech · 9/15/2026Read original →Luma locks down 15-year, $410M fund for life science investments
Fierce Biotech · 9/10/2026Read original →Mass. governor makes pre-election pitch to biotechs amid warning early-stage start-ups are 'dying'
Fierce Biotech · 9/11/2026Read original →Mayo Clinic teams with Thermo Fisher to form biomedical data group Precure
Fierce Biotech · 9/16/2026Read original →Medigen links up with Charles River in push to take enterovirus vaccine global
Fierce Biotech · 8/27/2026Read original →Medtronic earns FDA clearance for LigaSure use with its Hugo robotic system
Fierce Biotech · 9/21/2026Read original →Medtronic recalls reflux monitoring device as 184 serious injuries linked to capsule
Fierce Biotech · 9/2/2026Read original →Menarini signs $771M deal to take Gan & Lee GLP-1 to European market
Fierce Biotech · 9/7/2026Read original →Natera teams with Angiex on cancer drug trial monitoring
Fierce Biotech · 9/1/2026Read original →Newly formed Jaguar acquires Afib device assets from J&J
Fierce Biotech · 9/16/2026Read original →Novartis ends ALS program after phase 2 flop, adding to R&D woes
Fierce Biotech · 9/17/2026Read original →Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial
Fierce Biotech · 9/8/2026Read original →Novartis pays Sironax $125M to acquire platform for crossing the blood-brain barrier
Fierce Biotech · 9/17/2026Read original →Novartis secures new radioligand in $900M deal as competition strengthens
Fierce Biotech · 9/23/2026Read original →Novartis shareholder calls for board overhaul following costly deal setbacks: Reuters
Fierce Biotech · 9/11/2026Read original →Novartis telegraphs 130 job cuts amid biologics rethink in Switzerland
Fierce Biotech · 9/3/2026Read original →Novartis, Bristol Myers halt autoimmune CAR-T trials due to adverse events
Fierce Biotech · 9/1/2026Read original →Novo struggles to appease restive investors with consumer plans, blockbuster ambitions
Fierce Biotech · 9/22/2026Read original →Novo’s blockbuster hopes for CKD program dwindle after more phase 3 trials scrapped
Fierce Biotech · 9/8/2026Read original →Osivax bags flu vaccine rights to pursue combination shot vision
Fierce Biotech · 8/28/2026Read original →Pfizer offloads scrapped Seagen ADC to Medicus Pharma in up to $1B+ deal
Fierce Biotech · 9/4/2026Read original →Psilocybin proves promising in neuropathic pain mouse study
Fierce Biotech · 9/4/2026Read original →Qiagen appoints new chief executive after 9-month search
Fierce Biotech · 8/25/2026Read original →Rare EGFR mutation increases lung cancer risk 62 times in never smokers
Fierce Biotech · 9/18/2026Read original →Refreshed Novo corrals 3 new early-stage obesity drugs from Kallyope
Fierce Biotech · 9/21/2026Read original →Research into protein interactions sheds new light on causes of autism
Fierce Biotech · 8/28/2026Read original →Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody
Fierce Biotech · 9/2/2026Read original →Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test
Fierce Biotech · 8/25/2026Read original →Singapore launches biotech-focused Boston hub to build on 'centuries-old bond'
Fierce Biotech · 9/12/2026Read original →Sling reels in $123M series C to fund oral Tepezza rival through phase 3 trial
Fierce Biotech · 9/17/2026Read original →Spruce’s successful FDA talks plant seeds for Q4 filing of ultra-rare disease drug
Fierce Biotech · 8/25/2026Read original →Spyre's 3-pronged IBD strategy on track as IL-23 antibody rounds off trio of phase 2 wins
Fierce Biotech · 9/9/2026Read original →Teva autoimmune antibody notches ph. 2 win in celiac disease
Fierce Biotech · 9/3/2026Read original →Teva saddles up as stalking horse bidder for bankrupt BioXcel’s neuroscience portfolio
Fierce Biotech · 8/31/2026Read original →The future of RAS inhibitors
Fierce Biotech · 9/14/2026Read original →TME holds onto $1B dream for brain cancer drug as search for partners nears conclusion
Fierce Biotech · 8/25/2026Read original →Trump's Department of War bets $47M on Flagship biotechs to develop countermeasures
Fierce Biotech · 9/24/2026Read original →Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stock
Fierce Biotech · 9/10/2026Read original →Vertex’s midstage data amplify kidney disease market opportunity
Fierce Biotech · 9/23/2026Read original →Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug
Fierce Biotech · 8/24/2026Read original →White House plans to put NIH grants under political control: reports
Fierce Biotech · 9/22/2026Read original →Why a Texas congressman believes Chinese biotechs are 'beating us on our ground game'
Fierce Biotech · 8/26/2026Read original →Why Pheast’s CEO has no regrets about transparent approach to R&D despite competitors circling
Fierce Biotech · 8/24/2026Read original →Why Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical data
Fierce Biotech · 9/4/2026Read original →With mRNA back in the spotlight, tRNA shows potential to treat genetic disease
Fierce Biotech · 8/28/2026Read original →'Europe does not value what you do': 9 pharmas make urgent call for bloc to beef up innovation muscle
Fierce Pharma · 9/23/2026Read original →AbbVie chips in for neurology advocacy through PGA Tour birdie campaign
Fierce Pharma · 9/16/2026Read original →AbbVie lines up Qulipta expansion with phase 3 win in untapped menstrual migraine indication
Fierce Pharma · 9/11/2026Read original →Actor Kevin Costner does the math in Caris Detect early cancer detection push
Fierce Pharma · 9/10/2026Read original →After FDA nod for novel Cabometyx formulation, analysts predict limited threat to Exelixis
Fierce Pharma · 9/13/2026Read original →
After Trump order, RFK Jr. seeks input on US pediatric vaccine recommendations
Fierce Pharma · 8/25/2026Read original →Akeso, Summit’s ivonescimab tops Keytruda in lung cancer survival, with strong data in PD-L1-high patients
Fierce Pharma · 9/14/2026Read original →All 50 states apply to participate in new Medicaid drug pricing model, White House says
Fierce Pharma · 9/22/2026Read original →Amgen’s DLL3-targeted Imdelltra scores overall survival win in first-line small cell lung cancer
Fierce Pharma · 9/9/2026Read original →ARPA-H puts up $125M to bankroll personalized RNA-based drug production
Fierce Pharma · 9/3/2026Read original →As RevMed preps for ‘historic’ pancreatic cancer launch, questions linger on the ground
Fierce Pharma · 8/28/2026Read original →Ascendis to pay 20% Yuviwel royalties in patent settlement with BioMarin
Fierce Pharma · 9/1/2026Read original →AstraZeneca recommits to youth health to dial funding past $100M
Fierce Pharma · 9/24/2026Read original →AstraZeneca’s Etcamah flunks first-line breast cancer trial, adding to oral SERDs’ failure record
Fierce Pharma · 9/13/2026Read original →AZ leans on AI-generated llama to promote LAMA combo inhaler Breztri in new campaign
Fierce Pharma · 9/8/2026Read original →AZ, Daiichi's Enhertu scores long-awaited NICE blessing in HER2-low breast cancer
Fierce Pharma · 9/17/2026Read original →B. Braun adds to a string of IV solution recalls in US
Fierce Pharma · 9/1/2026Read original →Bausch + Lomb flops in ph. 2 with Xiidra and Miebo but advances combo to ph. 3
Fierce Pharma · 8/26/2026Read original →Bausch + Lomb survey reveals low dry eye awareness for perimenopausal, postmenopausal women
Fierce Pharma · 9/2/2026Read original →Baxter issues recall of 2 products after particulate concerns resurface
Fierce Pharma · 8/27/2026Read original →Bayer’s Kerendia secures FDA nod as first drug in 30 years for Type 1 diabetes-associated kidney disease
Fierce Pharma · 9/18/2026Read original →Biogen enlists lupus patient advocate to share social media story of resilience
Fierce Pharma · 8/29/2026Read original →BioMarin drops Voxzogo development for Noonan syndrome as treatment landscape shifts
Fierce Pharma · 9/16/2026Read original →BioMarin pads case for Voxzogo expansion as achondroplasia competition field shifts
Fierce Pharma · 9/10/2026Read original →BMS splashes out $173M to build 2nd radiopharmaceutical plant in Indiana
Fierce Pharma · 8/28/2026Read original →Bristol Myers cuts another 265 jobs tied to New Jersey headquarters
Fierce Pharma · 9/23/2026Read original →CDMO Argonaut sheds life sciences, diagnostics division for undisclosed sum
Fierce Pharma · 9/12/2026Read original →CDMO Lonza hones commercial focus with company vet's return to new role
Fierce Pharma · 9/1/2026Read original →Cellares downsizes New Jersey operations after losing BMS cell therapy contract
Fierce Pharma · 9/3/2026Read original →Cellares links with GenomeFrontier to test automation approach for virus-free CAR-Ts
Fierce Pharma · 9/17/2026Read original →Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks
Fierce Pharma · 9/24/2026Read original →Clinical trials reach a new automation inflection point
Fierce Pharma · 9/21/2026Read original →CMI boosts medical affairs capabilities with new specialty communications unit
Fierce Pharma · 9/4/2026Read original →Daiichi unit American Regent recalls 3 epinephrine batches on particulate, leakage concerns
Fierce Pharma · 9/8/2026Read original →Eight Trends Reshaping Patient-Centric Drug Development
Fierce Pharma · 9/9/2026Read original →Eli Lilly CEO touts 70% share as Medicare GLP-1 program reaches 700K seniors
Fierce Pharma · 9/24/2026Read original →Eli Lilly escalates oral SERD battle with FDA approval for Inluriyo, Verzenio combo
Fierce Pharma · 9/21/2026Read original →ESC: AZ, Ionis' Wainua post-mortem throws water on silencer-plus-stabilizer approach in ATTR-CM
Fierce Pharma · 8/31/2026Read original →Europe's CHMP endorses slew of new medicines, including new offerings from Novo and AZ
Fierce Pharma · 9/21/2026Read original →FDA approves Ultragenyx’s gene therapy Fayuvi for rare neurodegenerative disorder
Fierce Pharma · 9/18/2026Read original →FDA clears Bayer’s Hyrnuo in first-line lung cancer, amping up Hernexeos rivalry
Fierce Pharma · 9/10/2026Read original →FDA files reveal lingering concerns, contrasting views behind Replimune melanoma nod
Fierce Pharma · 9/4/2026Read original →Fierce Pharma Asia—Takeda’s R&D leadership change; Daiichi’s $1.3B court win; New Samsung Bio contract
Fierce Pharma · 9/13/2026Read original →Fresenius unit dinged in FDA warning letter flagging 'complaint trend' from customers
Fierce Pharma · 9/4/2026Read original →From Question to Action: Rethinking Pharma Engagement in the AI Era
Fierce Pharma · 9/8/2026Read original →Gilead christens Bixlenvo with FDA nod for new HIV treatment combo tablet
Fierce Pharma · 8/28/2026Read original →GSK makes ‘difficult decision’ to shutter German flu vaccine manufacturing site
Fierce Pharma · 9/15/2026Read original →GSK prepares frontline FDA bid for Jideytro, its first lung cancer drug
Fierce Pharma · 9/14/2026Read original →
Hansa lays groundwork for Nasdaq debut ahead of US kidney transplant drug verdict
Fierce Pharma · 8/25/2026Read original →How is API Manufacturing Changing?
Fierce Pharma · 9/15/2026Read original →In draft guidance, NICE rebuffs Gilead's twice-a-year PrEP med for national coverage
Fierce Pharma · 9/11/2026Read original →Increased deaths shadow AstraZeneca, Daiichi’s Enhertu first-line lung cancer data
Fierce Pharma · 9/14/2026Read original →IntraBio's Aqneursa scores expansion, now the first treatment for rare ataxia
Fierce Pharma · 9/22/2026Read original →Ionis’ ‘breakthrough’ Alexander disease approval establishes pillar of rare disease pipeline
Fierce Pharma · 9/8/2026Read original →J&J firms up Caplyta's 1st phase 3 win in bipolar-associated manic episodes
Fierce Pharma · 9/22/2026Read original →Jazz's HER2 bispecific Ziihera gains FDA approval to change practice in stomach cancer
Fierce Pharma · 8/26/2026Read original →Lilly scores Novo-pressuring Mounjaro expansion to curb heart risks in diabetes patients
Fierce Pharma · 8/31/2026Read original →
Lundbeck continues neuroscience evolution as CEO keeps company ‘punching above its weight’
Fierce Pharma · 8/24/2026Read original →McKesson strikes $2.25B deal to snap up Precision Medicine Group
Fierce Pharma · 8/26/2026Read original →Merck trims another 54 jobs in New Jersey amid multiyear cost-cutting initiative
Fierce Pharma · 9/10/2026Read original →
Merck, AZ lawsuits against Medicare price negotiations swatted down
Fierce Pharma · 8/25/2026Read original →Merck, Gilead’s failed Trodelvy lung cancer trial shows better China results
Fierce Pharma · 9/14/2026Read original →MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check
Fierce Pharma · 8/31/2026Read original →Novartis claims MS win as Rhapsido clears phase 3 with ‘no liver safety signal’
Fierce Pharma · 9/2/2026Read original →Novartis puts MS advocacy on the podium through social media partnership with British Olympian
Fierce Pharma · 9/4/2026Read original →Novo CEO sees advantages in souping up NYSE listing: report
Fierce Pharma · 9/24/2026Read original →Novo Nordisk’s Wegovy helps free 40% of kids from obesity in phase 3 trial
Fierce Pharma · 9/9/2026Read original →Par Health recalls IV sedative in US, flagging presence of cellulose, stopper material
Fierce Pharma · 9/23/2026Read original →PhRMA's Medicare price negotiation suit rebuffed in latest blow to industry IRA challenge
Fierce Pharma · 8/28/2026Read original →
Regulatory tracker: FDA updates for Merck's Winrevair, Nuvation's Ibtrozi lead regulatory deluge
Fierce Pharma · 9/23/2026Read original →Roche’s Lunsumio delivers positive confirmatory trial readout in follicular lymphoma
Fierce Pharma · 9/18/2026Read original →Sandoz sets sights on 100 biosimilars in new 2040 strategy, with $300M facility build
Fierce Pharma · 9/9/2026Read original →Sanofi strikes Cheplapharm deal to divest 20 older medicines as CEO pushes for innovation
Fierce Pharma · 9/16/2026Read original →Scholar Rock scores long-awaited FDA approval, the first for muscle loss in SMA
Fierce Pharma · 9/15/2026Read original →Shionogi taps The Bloc for omnichannel campaign backing COVID-19 pill Xocova
Fierce Pharma · 9/16/2026Read original →Swiss CDMOS making moves: Lonza bets on new US facility, CordenPharma scales injectables with €80M
Fierce Pharma · 9/11/2026Read original →Takeda bolsters blood cancer portfolio with FDA nod for Mimrylo in polycythemia vera
Fierce Pharma · 8/31/2026Read original →
The Oral GLP-1 Tracker: Holiday takes toll on prescriptions
Fierce Pharma · 9/21/2026Read original →The people who stayed with the problem
Fierce Pharma · 9/7/2026Read original →Trialynx Wins DPHARM Idol Disrupt 2026
Fierce Pharma · 9/17/2026Read original →Trump calls for some childhood vaccines be split into smaller doses
Fierce Pharma · 9/22/2026Read original →Trump GLP-1 update teases blockbuster annual sales for Lilly from Medicare program: analyst
Fierce Pharma · 9/3/2026Read original →Vera’s strong phase 3 IgAN data for Trutakna intensify kidney disease rivalry
Fierce Pharma · 9/17/2026Read original →
What did we learn from Big Pharma’s Q2 results?
Fierce Pharma · 8/24/2026Read original →White House unveils next round of MFN pricing deals with 9 midsized drugmakers
Fierce Pharma · 9/1/2026Read original →Why Earlier Commercial Involvement Drives Smarter Strategy
Fierce Pharma · 9/15/2026Read original →
‘Molecular Movie’ of Penicillin Synthesis Could Inform Future Antibiotic Development
GEN · 10/9/2026Read original →
‘One-Two Punch’ Targets Resistance Mechanism in Aggressive Triple-Negative Breast Cancer
GEN · 8/31/2026Read original →
A Method for Assessing Lab-Grown Stem Cell-Derived Embryo Models
GEN · 10/6/2026Read original →
ADC Developmentfrom Concept to Clinic
GEN · 10/17/2026Read original →
ADCs, mAbs, CAR Ts: One Bioluminescent Platform Measures Them All
GEN · 9/9/2026Read original →
Advanced Imaging Technique Reveals Immune Cell Metabolic States in Blood Samples
GEN · 9/2/2026Read original →
Advancing AAV Development: From Production to Performance
GEN · 9/22/2026Read original →
Advancing Cell Therapy for Cardiovascular Disease
GEN · 9/22/2026Read original →
AI Drug Discovery Hits a New Bottleneck: Experimental Validation
GEN · 9/9/2026Read original →
AI Tool Helps Link BRSK1 Variants to Neurodevelopmental Disorder
GEN · 9/29/2026Read original →
Alzheimer’s Small-Molecule Therapy Shows Promise in Mice and Early Human Trial
GEN · 10/14/2026Read original →
Ancient Peptides Resurrected from Lactoferrin’s Evolutionary Past Could Point to New Antibiotics
GEN · 8/27/2026Read original →
Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy
GEN · 9/2/2026Read original →
Anti-Inflammatory Drug Target for Alzheimer’s, TBI, and Neurodegenerative Disease Identified
GEN · 10/6/2026Read original →
Antibody Blocks T Cell Infiltration and Limits Neurodegeneration in Alzheimer’s Mice
GEN · 9/29/2026Read original →
APOE4 Linked to Potentially Reversible Mechanisms of Brain Blood Vessel Damage in Alzheimer’s
GEN · 9/25/2026Read original →
Aprea Expands Development of WEE1 Inhibitor After Seeing Early Clinical Activity Signs vs. Cancer
GEN · 8/27/2026Read original →
ARPA-H’s BoSS Program Funds Three Teams Tackling Cold Chain Challenges for Cell Therapies
GEN · 10/9/2026Read original →
Asahi Kasei Introduces VANTIJ® SU-VFC Benchtop Virus-Filtration System
GEN · 9/18/2026Read original →
ASHG: Long-Read Genomics Meets Clinical Data in PacBio, Verily Health AI Deal
GEN · 10/20/2026Read original →
Autism Target Discovered in Endothelial Cells in Genetic Deletion Mouse Model
GEN · 10/1/2026Read original →
Biologics Standards for Innovation, Quality and Access
GEN · 10/7/2026Read original →
Biomimetic Nanoparticles Trigger Light Responses in Blind Mouse Retinas
GEN · 9/23/2026Read original →
Bone Marrow-on-a-Chip Model Offers New Window Into Immune Cell Development and Behavior
GEN · 9/12/2026Read original →
Brain Protein in Mice Offers Insights Into Brain Development and ADHD
GEN · 9/17/2026Read original →
C. difficile Have Lasting Effects on the Infant Gut, Challenging Long-Held Assumption
GEN · 9/4/2026Read original →
Cancer Drug Reduces SIV Reservoir in Macaques, May Inform HIV Cure Strategies
GEN · 9/4/2026Read original →
CAR T-Cell Therapy Puts Severe Rheumatoid Arthritis Into Remission in First Clinical Trial
GEN · 8/28/2026Read original →
Cell Senescence ‘Barcodes’ Identified with Raman Microscopy and Gene Expression Data
GEN · 9/23/2026Read original →
Cell Therapy Manufacturing Takes Shape Across Asia-Pacific
GEN · 10/14/2026Read original →
Cellares and GenomeFrontier Therapeutics Partner to Advance Automated Manufacturing of GF-CART01
GEN · 9/16/2026Read original →
Chronic Interferon Exposure Linked to Immunosuppression in Cancer
GEN · 9/11/2026Read original →
CloudScope Enables Continuous Remote Monitoring of Brain Activity in Freely Moving Mice
GEN · 9/11/2026Read original →
Consolidating Antibody Discovery Data with an AI Platform
GEN · 9/15/2026Read original →
Converted Human Pancreatic Duct Cells Show Diabetes Therapy Potential
GEN · 9/2/2026Read original →
Current Challenges in CAR T Manufacturing
GEN · 9/29/2026Read original →
Danaher, Nvidia Combine Lab Instrumentation and AI to Advance Autonomous Science
GEN · 10/17/2026Read original →
DANDELION Computational Tool Identifies Previously Unknown Asthma-Related Genes and Pathway
GEN · 8/21/2026Read original →
Designing Peptide Screens to Generate Knowledge, Not Just Hits
GEN · 10/1/2026Read original →
Designing the Ecosystem for CGT Success
GEN · 10/16/2026Read original →
Diasome’s HDV-Insulin for T1D Finalizing Phase III Plans After Promising Data
GEN · 10/18/2026Read original →
Digital Shadows to Aid Complexity in Handling Process Intensification
GEN · 9/23/2026Read original →
DNA Typewriter, PEtracer Map Mouse Development Through Organogenesis
GEN · 10/9/2026Read original →
Electrical Signals Sharpen Bioprocess Control
GEN · 10/7/2026Read original →
Emerging Trends in Fluid Transfers and Freeze-Thaw Workflows
GEN · 9/22/2026Read original →
Enodia Therapeutics Inks Pfizer Deal to Develop Sec61-Targeting Small Molecules
GEN · 10/13/2026Read original →
Evonik Expands in Slovakia
GEN · 9/15/2026Read original →
Exosomes Linked to Nerve Irritation, Dysfunction, and Lingering Pain After Shingles
GEN · 9/16/2026Read original →
Expanded Synthetic Promoter Library Introduced to Boost Biomanufacturing Operations
GEN · 8/25/2026Read original →
Exposure to Common Endocrine-Disrupting Chemicals May Alter Normal Breast Development
GEN · 10/16/2026Read original →
Extracellular Secretion System Could Solve Industry Endonuclease Production Challenges
GEN · 8/26/2026Read original →
FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates
GEN · 10/3/2026Read original →
Five-Year Brain Organoids Reveal New Insights Into Human Development
GEN · 8/21/2026Read original →
Flicking the Switch: Five Scientists Honored at 2026 Warren Alpert Foundation Symposium for Hemoglobinopathy Research
GEN · 10/6/2026Read original →
For Biocatalysis, Solvents Are a Key Bioprocessing Parameter
GEN · 10/14/2026Read original →
From Discovery to Development
GEN · 10/9/2026Read original →
From Images to Data
GEN · 8/28/2026Read original →
From Models to Agents: The Next Phase of AI Adoption in Molecular Discovery
GEN · 8/21/2026Read original →
GBI Biomanufacturing Set to Launch SmartScale GMP Solutions
GEN · 9/18/2026Read original →
Gene Therapy Extends Lifespan and Reduces Symptoms in Sandhoff Disease Cat Model
GEN · 9/9/2026Read original →
Genes Involved in Flatworm Brain Regeneration Identified
GEN · 9/22/2026Read original →
Genetic Toolkit Isolates Neuron Types in Drosophila Brain
GEN · 8/28/2026Read original →
Genialis and Inventia Life Science Collaborate to Link Patient Biology with 3D Pancreatic Cancer Models
GEN · 9/24/2026Read original →
Genome-Wide Analysis Identifies BACH2 as Potential Fetal Hemoglobin Activation Target
GEN · 10/1/2026Read original →
Ginkgo Datapoints, Apheris Announce Founding Members of Antibody Developability Consortium
GEN · 9/29/2026Read original →
GLP-1 Drug Semaglutide Slows Aging and Extends Lifespan in Mice
GEN · 9/3/2026Read original →
Gut Microbes Trigger Calprotectin to Protect Newborns from Infection
GEN · 10/8/2026Read original →
High-Grade Glioma Biology Varies by Age and Sex, Revealing Potential Treatment Targets
GEN · 9/17/2026Read original →
How Alzheimer’s Risk Gene APOE4 Disrupts Myelination
GEN · 10/15/2026Read original →
How Bladder Cells Fight Hidden E. coli: New Insights Into Recurrent UTIs
GEN · 9/25/2026Read original →
How Cells Respond Differently to a Cancer-Causing Gene
GEN · 9/29/2026Read original →
How Preclinical Manufacturing Can De-Risk the Path to GMP-Ready Viral Vector Programs
GEN · 10/9/2026Read original →
Hybrid Digital Twins Developed for Future Autonomous Labs
GEN · 10/7/2026Read original →
Illumina Combines Multiomics Informatics Applications in New BioInsight Platform
GEN · 10/15/2026Read original →
Immune Cell Atlas Charts How People’s Aging Paths Diverge
GEN · 10/9/2026Read original →
Immune Cells Driving Alzheimer’s-Like Neurodegeneration Traced to Lymph Nodes
GEN · 9/4/2026Read original →
In Massachusetts, Latest Annual Snapshot Shows a Tale of Two Biopharmas
GEN · 8/26/2026Read original →
Increasing CHO Cell Productivity
GEN · 9/9/2026Read original →
Inhaled Suppressor tRNA Restores Gene Function in Cystic Fibrosis Models
GEN · 8/27/2026Read original →
Intense Media Pressure an Emerging Challenge in CHO Business
GEN · 9/25/2026Read original →
JNC Targets Bigger Molecules with Cellufine
GEN · 9/25/2026Read original →
Key Immune Cells Identified That Could Strengthen Flu Vaccines
GEN · 8/31/2026Read original →
Kidney Organoids Reveal Inflammatory Drivers of Diabetic Kidney Disease
GEN · 9/18/2026Read original →
Lab-Grown Neocortex Models Mimic Early Brain Organization
GEN · 8/21/2026Read original →
Landmark UK Biobank, IMU Immune Profiling Initiative Taps Ultima and Waters
GEN · 10/20/2026Read original →
Lilly’s GIP/GLP-1 Candidate Brenipatide Shows Early Clinical Promise in Substance, Psych Disorders
GEN · 9/19/2026Read original →
Lock Down the Critical Factors in Oligo and Oligo-Conjugate Characterization with Stunner and Honeybun
GEN · 10/7/2026Read original →
Male Sex Hormones Suppress Lung Allergies by Acting on Neurons in Mice
GEN · 8/24/2026Read original →
Manus and UT Austin Advance Biomanufacturing Product Recovery Through BioMADE Program
GEN · 9/10/2026Read original →
Medicines Discovery Catapult Backs Two U.K. Biotech Companies Tackling Chronic Diseases
GEN · 9/4/2026Read original →
Merck, SciBrunch Launch Up-to-$2.13B Collaboration to Develop Preclinical KRAS-Inhibiting Molecular Glue
GEN · 9/30/2026Read original →
Micro-Bladder Model Demonstrates How Phage Therapy Could Help to Reduce Recurrent UTIs
GEN · 9/4/2026Read original →
Mitochondrial Transporter Connects Body Clock and Diet to Fat Burning
GEN · 10/2/2026Read original →
Molecular Devices and STEMCELL Technologies Team Up to Automate Organoid Research
GEN · 9/18/2026Read original →
Molecular Pathways Driving Autoantibody Production Following SARS-CoV-2 Infection Identified
GEN · 8/28/2026Read original →
Monoclonal Antibodies Targeting MMP-9 Alleviate Peripheral Neuropathy in Diabetic Mice
GEN · 9/9/2026Read original →
MRSA Exploits Kidney’s Inner Environment to Persist and Spread
GEN · 10/1/2026Read original →
Multiomics in 2026 and Beyond
GEN · 10/9/2026Read original →
Muscle Cell Calcium Channel Structure, Synchronicity Could Advance Muscle Disease Therapeutics
GEN · 9/25/2026Read original →
Myotis Bat Genomes Reveal How They Fight Viruses, Cancer, and Cellular Damage
GEN · 8/26/2026Read original →
Navigating the Regulatory Labyrinth: How Biotech Leaders Are Rethinking Strategy in an Uncertain Regulatory Era
GEN · 9/3/2026Read original →
Neural Mechanism Identified That Drives Increased Alcohol Use in Isolated Male Mice
GEN · 8/25/2026Read original →
Neurons Involved in Generating Anxiety After Cannabinoid Drug Exposure Identified in Mice
GEN · 10/3/2026Read original →
New Calibration Framework Improves Confidence in AI Virtual Cell Models
GEN · 10/7/2026Read original →
New CRISPR-Based Tool Enables Genome-Wide Mutagenesis of Bacteriophages
GEN · 9/25/2026Read original →
New Cytometry Technique for Characterizing Viral Vectors
GEN · 8/26/2026Read original →
New Liposome Design Could Provide Effective Slow-Release Drug Delivery System
GEN · 9/24/2026Read original →
New Spectrometry Technique Could Aid Formulation Development
GEN · 9/2/2026Read original →
NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy
GEN · 9/5/2026Read original →
Newly Identified Microexons Offer Clues to Autism Spectrum Disorder’s Genetic Roots
GEN · 10/15/2026Read original →
Notch Signaling Switch Enables Scalable Helper T Cell Production for CAR T
GEN · 8/28/2026Read original →
NRAS Mutations May Require Mutation-Guided Combination Therapies
GEN · 9/9/2026Read original →
Nu-Tek Brings Topic of Raw-Material Risk to BPI
GEN · 9/18/2026Read original →
One Standard, Multiple Platforms: ICH Q2(R2) Qualification of Host Cell Protein Analysis by LC–MS/MS
GEN · 8/25/2026Read original →
PARP Inhibitor Combination Therapy Boosts Antitumor Activity in NSCLC Models
GEN · 8/25/2026Read original →
PD-L2 Blockade May Reduce Harmful Aging Cell Buildup
GEN · 9/11/2026Read original →
Phage Proteases Trigger a Conserved Bacterial Antiviral Defense Pathway
GEN · 10/6/2026Read original →
Pneumococcal Subtypes Influence the Impact of Air Pollution on Disease Risk
GEN · 9/14/2026Read original →
Preterm Birth for Some Women Linked to Specific Autoantibodies
GEN · 10/14/2026Read original →
Prime Assembly Expands Genome Editing with Precise, Large-Scale DNA Integration
GEN · 9/16/2026Read original →
Prophylactic Phage Therapy Protects Mice Against Oral Salmonella Infection
GEN · 9/17/2026Read original →
Proteomics Maps Eye-Infecting Acanthamoeba Mitochondria Across Oxygen Levels
GEN · 10/2/2026Read original →
Proteomics Reveals Ovarian Remodeling Decades After Menopause
GEN · 10/16/2026Read original →
Psilocybin Prevents Chemotherapy-Related Peripheral Neuropathy in Mice
GEN · 9/3/2026Read original →
Psychological Stress Triggers Arthritis Flares in Mice via IL-6-Dependent Pathway
GEN · 10/19/2026Read original →
Right Resin, Right Order: A Two-Step Polishing Strategy for Bispecific Antibodies
GEN · 9/15/2026Read original →
Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development
GEN · 8/24/2026Read original →
Samsung Biologics Signs $262 Million Manufacturing Agreement with European Pharma Firm
GEN · 9/11/2026Read original →
Sartorius and NIBRT Partner on Intensified and Continuous Bioprocessing Training Center
GEN · 9/17/2026Read original →
Scientists Observe Enzymes Breaking Down DNA in Real Time
GEN · 9/28/2026Read original →
Secrets of Oldest Land Animal’s 194-Year Lifespan Revealed with Epigenetics
GEN · 10/8/2026Read original →
Shionogi Grows Rare Disease Portfolio with $2B IntraBio Acquisition
GEN · 10/7/2026Read original →
Sickle Cell Trait Linked to Distinct Malaria Parasite Variants
GEN · 10/10/2026Read original →
Single-Cell Striatum Atlas Reveals Neurological Disorder Vulnerabilities
GEN · 9/2/2026Read original →
Single-Use Comes of Age—What Comes Next?
GEN · 9/1/2026Read original →
Small Molecules, Big Expectations: How CDMOs Are Helping Sponsors Navigate Complexity, Speed, Scale-Up, and Sustainability
GEN · 8/25/2026Read original →
Spatial Transcriptomics Tools May Link Tumor Organization to Treatment Response
GEN · 9/1/2026Read original →
StockWatch: Caribou Plunges as It Pursues Strategic Alternatives
GEN · 10/13/2026Read original →
StockWatch: Liquidia Rebounds After Settling Legal Wrangle with United Therapeutics
GEN · 10/19/2026Read original →
StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too
GEN · 8/23/2026Read original →
StockWatch: Nektar Shares Flat as $90M Jury Verdict Less than Sought in Lilly Suit
GEN · 9/28/2026Read original →
StockWatch: Novartis Loses More than Market Value After Phase III Failure
GEN · 9/14/2026Read original →
StockWatch: Novo’s 2030 Strategy Underwhelms Investors at Capital Markets Day
GEN · 9/22/2026Read original →
StockWatch: Revolution Shares Stay Flat Despite Historic FDA Approval of Oral Pancreatic Cancer Therapy
GEN · 8/30/2026Read original →
Stroke Remodels Tumor Microenvironment to Promote Glioma Growth
GEN · 9/25/2026Read original →
Syngene Expands Integrated Drug Development and Manufacturing Services with BMS
GEN · 9/22/2026Read original →
Talus Bio’s Structure-Free AI Model Targets Unstructured Proteins in Their Native Cellular Context
GEN · 10/2/2026Read original →
Tautomer-Predictor AI Tool Identifies Stable Molecules for Drug Discovery
GEN · 9/24/2026Read original →
Thar Process Partners with ExtrateX to Bring Prep to Process-Scale SFC to Europe
GEN · 9/25/2026Read original →
The Analytical Blueprint for Cell & Gene Therapy Success
GEN · 9/3/2026Read original →
The Emerging Power of Mass Spectrometry in Oncology
GEN · 9/10/2026Read original →
The Multi-Attribute Method (MAM) as a Biologics Lifecycle Backbone
GEN · 9/9/2026Read original →
The Top 10 Questions Shaping the Future of Optogenetic Biomanufacturing
GEN · 10/13/2026Read original →
Time-Restricted Eating Linked to Improved Huntington’s Disease Markers
GEN · 9/18/2026Read original →
TraceIQ Launched to Maximize Pharmaceutical Traceability
GEN · 9/2/2026Read original →
Transcenta Therapeutics and WuXi Biologics Team Up to Accelerate Commercialization of HiCB Technology
GEN · 9/11/2026Read original →
UCB Dedicates Future U.S. Biologics Manufacturing Campus in Georgia
GEN · 10/13/2026Read original →
UCSF QBI Awarded $46M to Translate Landmark Autism Map Into Precision Therapies
GEN · 8/27/2026Read original →
Viral Protein Helps Self-Amplifying RNA Overcome Cellular Defenses
GEN · 9/28/2026Read original →
Watching Cancer Proteins in Real Time, with Help from Rare Earth Elements
GEN · 10/3/2026Read original →
What 25 Years of Research Have Revealed About 9/11’s Long-Term Health Effects
GEN · 9/11/2026Read original →
Why Does a Particular Genetic Variant Lead to Accelerated Huntington Disease Development?
GEN · 9/14/2026Read original →
X-Chromosome Gene Linked to Increased Autism Diagnosis in Males
GEN · 10/13/2026Read original →
Brazil’s biodiversity is the engine of a new bioeconomy
Good Food Institute · 8/14/2026Read original →
Building an alt protein community at Brown University and beyond
Good Food Institute · 5/22/2026Read original →
China, alternative proteins, and the next stage for Brazilian agriculture.
Good Food Institute · 10/6/2026Read original →
European Food Safety Authority sets out priorities to keep pace with food innovation
Good Food Institute · 10/13/2026Read original →
Germany’s High-Tech Agenda: innovation hub for alternative proteins could support economic growth
Good Food Institute · 5/21/2026Read original →Our climate is changing, and so must our food system.
Good Food Institute · 9/27/2026Read original →
The Alt Protein Project welcomes 15 new student groups
Good Food Institute · 8/11/2026Read original →
The future of food is being decided now
Good Food Institute · 5/20/2026Read original →
The secret recipe: bringing protein innovation into the classroom
Good Food Institute · 10/10/2026Read original →
World Health Organization plans landmark report on sustainable food systems
Good Food Institute · 10/14/2026Read original →
‘Brewed Protein’ Startup Spiber Opens Biofoundry to Produce Fermentation-Derived Products
Green Queen · 10/5/2026Read original →
‘Hot Girl Soda’: Female-Founded Feisty Bags Funding for Fizzy Plant Protein Drinks
Green Queen · 9/9/2026Read original →
‘Natural Protein’: La Vie Brings Tofu Range to UK Amid Whole-Food Rush
Green Queen · 9/23/2026Read original →
57% of Americans Think UPFs Can’t Be Healthy, As Wait for Federal Definition Continues
Green Queen · 10/16/2026Read original →
80% of People Can’t Tell the Difference Between Cocoa Butter & A Yeast-Derived Substitute
Green Queen · 9/21/2026Read original →
94% of Urban Indians Would Buy Cultivated Meat, Driven by Protein & Health Appeal
Green Queen · 10/8/2026Read original →
AAK to Produce Cocoa Butter Alternatives with Dry Fractionation Tech in Malaysia
Green Queen · 10/6/2026Read original →
Abu Dhabi Enables Pre-Approval Tastings of Cultivated Meat & Precision-Fermented Foods
Green Queen · 10/12/2026Read original →
ADM Gets $2.2M Award from Iowa State to Expand Precision Fermentation Capacity in Clinton
Green Queen · 8/24/2026Read original →
Äio, TFTAK Get $2.6M from Estonian Govt to Enhance Waste-Fermented Yeast Fat Production
Green Queen · 8/28/2026Read original →
Äio, Tilk Launch Skin-Boosting Face Cream with Two Waste-Fermented Yeast Fats
Green Queen · 9/11/2026Read original →
Algiecel Opens Microalgae Facility at Novonesis Site to Scale Up Fish Oil Alternatives
Green Queen · 10/12/2026Read original →
Alpro Launches Greek-Style Yoghurt Prioritising ‘Extra Creamy’ Texture Over Protein
Green Queen · 9/1/2026Read original →
Australia’s OMG Group Nabs Fresh Funding to Help Expand Protein Oat Milk Line
Green Queen · 9/3/2026Read original →
Ayana Bio, Zenfold Buy Meati Foods’s Fermentation Assets to Scale Plant Cell Culture Platform in India
Green Queen · 9/18/2026Read original →
Backed by Novo Nordisk Foundation, React Foods Turns Gases Into Whey & Egg Protein Replacers
Green Queen · 9/22/2026Read original →
Beans, Clean Labels & Zero Waste 2.0 Star in Whole Foods Market’s 2027 Food Trends
Green Queen · 10/15/2026Read original →
Belgium’s Maash Brews Up $14M in Funding to Fuel Industrial-Scale Mycoprotein Production
Green Queen · 8/27/2026Read original →
Believe in Tempeh, Not Chicken: Better Nature Takes on KFC As Brits Seek New Protein Options
Green Queen · 9/10/2026Read original →
Beyond Ground Faba, Rubisco Protein & Microbial Silk Among Time’s Best Inventions of 2026
Green Queen · 10/16/2026Read original →
Beyond Meat Brings Plant Protein Drinks to California with Erewhon Launch
Green Queen · 8/25/2026Read original →
Beyond Meat Debuts Whole-Cut Mycelium Steak Filet at Erewhon
Green Queen · 9/16/2026Read original →
Beyond Meat Expands Immerse Range with Caffeinated Energy Drinks & New Flavours
Green Queen · 10/16/2026Read original →
Beyond Meat Taps NHS Doctor & TV Fitness Influencer for UK Healthy Eating Campaign
Green Queen · 8/26/2026Read original →
Beyond Meat, Quorn & Food Industry Urge EU to Reject Extension of Plant-Based Labelling Ban
Green Queen · 10/8/2026Read original →
Beyond Meat’s Starmatter Protein Powder Gets Clean-Label Purity Award
Green Queen · 10/14/2026Read original →
Beyond Taste or Health, Plant-Based Meat Faces Barriers from Nostalgia & Cultural Traditions
Green Queen · 8/21/2026Read original →
Biotech Open Platform: Danone, Michelin & Co Open €20M Precision Fermentation Facility
Green Queen · 9/30/2026Read original →
Brazilian Researchers File Patent for Waste-Fermented Aromas to Enhance Plant-Based Meat
Green Queen · 8/25/2026Read original →
Burger King Debuts Plant-Based Crispy Chicken Burger in Austria
Green Queen · 9/9/2026Read original →
Can Marine Industry Waste Unlock the Potential of Hybrid Seafood?
Green Queen · 10/19/2026Read original →
Can Oyster Mushrooms Unlock the Umami Potential of Tofu’s Protein-Rich Byproduct?
Green Queen · 10/15/2026Read original →
Canada Govt Bets on Domestic Plant Proteins to Advance Food Supply Chain
Green Queen · 10/8/2026Read original →
Canada’s Yves Veggie Cuisine ‘Back By Popular Demand’ with Maple Leaf Foods Acquisition
Green Queen · 9/15/2026Read original →
CarbonFarm Gets $7.8M to Expand AI-Assisted Rice Decarbonisation Tech Globally
Green Queen · 10/13/2026Read original →
Cats Like This Cultivated Meat Treat Just As Much As Chicken
Green Queen · 10/13/2026Read original →
Christina Tosi’s Milk Bar Debuts Beyond Meat Dishes to Meet ‘Plant-Forward’ Demand
Green Queen · 8/27/2026Read original →
Clean-Label Plant-Based Milk Maker Three Trees Scooped Up by Next in Natural
Green Queen · 10/1/2026Read original →
Cremer’s FermBase Launches High-Performing Yeast Blend for Fermentation Startups
Green Queen · 9/18/2026Read original →
Denmark’s Cellugy Brings Fossil-Free Skincare Production to Industrial Scale
Green Queen · 10/19/2026Read original →
Dutch Consortium to Advance Continuous Precision Fermentation for Alternative Proteins
Green Queen · 10/7/2026Read original →
Dutch Govt Urged to Develop National Plant-Based Strategy with €65M Annual Fund
Green Queen · 9/14/2026Read original →
Easy Mince: Heck Introduces Blended Meat Range with Beans & Vegetables in UK
Green Queen · 9/21/2026Read original →
EFSA Admits Need to Boost Regulatory Expertise & Clarity for Novel Foods
Green Queen · 10/9/2026Read original →
EU Research Strategy Ignores Funding for Alternative Protein Despite Scale-Up Goals
Green Queen · 9/14/2026Read original →
EU-Backed Startup Develops Superior Cultivated Meat Inputs That Could Benefit GLP-1 Users
Green Queen · 8/28/2026Read original →
Europe’s Alternative Protein Sector Sees 56% Bump in Funding in 2026
Green Queen · 8/31/2026Read original →
European Think Tank Launches Regulatory Sandbox for Novel Food Startups
Green Queen · 10/15/2026Read original →
Exclusive: Cultigen Group Connects B2B Cultivated Meat Platforms Under New Research Layer
Green Queen · 10/7/2026Read original →
Female-Founded Bare Beans Bags $2.8M & Launches Ready-to-Eat Legumes
Green Queen · 10/9/2026Read original →
Fewer Americans Consider Processing Levels Before Buying Food, Shows Survey
Green Queen · 9/7/2026Read original →
France’s Edonia Nets $16.8M to Ramp Up Production of Ground Spirulina Protein
Green Queen · 10/7/2026Read original →
Freezing Lentils Can Unlock Meat-Like Fibrous Textures with Minimal Processing
Green Queen · 9/7/2026Read original →
French Govt Invests €3.7M in Nūmi to Scale Up Cell-Cultured Breast Milk
Green Queen · 9/2/2026Read original →
From Samosas to Momos, India’s High Time Foods Eyes Familiarity with Plant-Based Protein Snacks
Green Queen · 9/21/2026Read original →
Future Food Quick Bites: Alpro x McDonald’s, Leon Shiitake Burger & Vegan Hospitality
Green Queen · 9/2/2026Read original →
Future Food Quick Bites: Better Nature Tempeh, Protein Cereals & Vegan-Friendly Bundesliga
Green Queen · 8/26/2026Read original →
Future Food Quick Bites: Caramel Waffle Milk, Food Waste Flavours & Blue Bottle
Green Queen · 10/14/2026Read original →
Future Food Quick Bites: École Ducasse, BuzzFeed Tasty & Toddler Milk
Green Queen · 9/23/2026Read original →
Future Food Quick Bites: Horchata Creamer, Cultivated Pet Food & Blended Meat in NYC
Green Queen · 9/9/2026Read original →
Future Food Quick Bites: Indian Protein Toppers, Planted at Starbucks & Google x Mitti Labs
Green Queen · 9/16/2026Read original →
Future Food Quick Bites: Mung Bean Bits, Accro Protein Strips & Hackney Ad Ban
Green Queen · 10/7/2026Read original →
Future Food Quick Bites: The Vegetarian Butcher, Protein Chocolate & Non-Dairy Sales
Green Queen · 9/30/2026Read original →
Fysh Foods: Beyond Sushi Owner Scoops Up Shark Tank’s Influencer-Led Vegan Seafood Brand
Green Queen · 9/1/2026Read original →
Gas Protein Firm Solar Foods Becomes Foundational Member of Deep Space Food Consortium
Green Queen · 10/19/2026Read original →
GLP-1 Users Plan to Spend More on Protein & Fibre – Can Food Companies Capitalise?
Green Queen · 9/3/2026Read original →
Going Ham: EU Lawmakers Seek to Expand Scope of ‘Veggie Burger’ Labelling Ban
Green Queen · 8/27/2026Read original →
Greencovery Raises €1M to Upycled Cocoa Waste Into Functional Ingredients
Green Queen · 9/18/2026Read original →
Greenforce Poaches Vegan Egg Maker Neggst Ahead of Acquisition by Livekindly Collective
Green Queen · 10/2/2026Read original →
Gutgevity: Bactolife Launches Binding Proteins in US to Supercharge Gut Health Market
Green Queen · 9/30/2026Read original →
High-Protein, High-Fibre: Daring Foods Drops Frozen Skillet Meals with Plant-Based Chicken
Green Queen · 9/1/2026Read original →
Higher Protein, Higher Yield: Ever After Foods, Roslin Technologies Make Cultivated Meat Breakthrough
Green Queen · 10/13/2026Read original →
Horlicks Becomes Latest Entrant to India’s Yeast Protein Powder Wave
Green Queen · 9/17/2026Read original →
How Dreamfarm Defied the Vegan Cheese Hate with 45% Growth & A Flexitarian Focus
Green Queen · 10/9/2026Read original →
How Planted is Outpacing Competitors in Europe’s Largest Plant-Based Meat Market
Green Queen · 9/18/2026Read original →
How Waste Valorisation Can Create Profitable Plant-Based Businesses
Green Queen · 9/29/2026Read original →
Humble Edition: Planet Oat Releases Five-Ingredient Oat Milk with Banana Purée
Green Queen · 9/2/2026Read original →
Impossible Foods Launches Plant-Based Beef Burger & Whole-Muscle Chicken in the UK
Green Queen · 9/23/2026Read original →
Indian State-Backed Hub Develops Six Plant-Based Protein Bars from Local Pulses
Green Queen · 9/11/2026Read original →
IntegriCulture, ImpacFat to Develop Next-Gen Cosmetics with Cultivated Fish Fat
Green Queen · 10/5/2026Read original →
Irish Govt Urged to Create National Plant-Based Food Fund in Budget 2027
Green Queen · 9/25/2026Read original →
Japan’s Aeon Taps Fuji Oil to Expand Cocoa-Free Chocolate Line
Green Queen · 9/15/2026Read original →
Judge Slashes Beyond Meat’s Damages by $23.4M in Dunkin’ Trademark Lawsuit
Green Queen · 9/23/2026Read original →
Landish Unveils Five-Plant Protein Powder Featuring Plantible Foods’s Rubisco
Green Queen · 9/29/2026Read original →
Lidl Launches Blended Meat in the UK, with At Least 20% More Protein
Green Queen · 9/17/2026Read original →
Lindt-Backed Food Brewer Brings Cocoa-Free Chocolate to SBB Trains Across Switzerland
Green Queen · 9/29/2026Read original →
Loacker Teams Up with Endless Food Co to Support Bean-Free Chocolate Development
Green Queen · 9/16/2026Read original →
Maple Leaf Foods to Consolidate US Plant Protein Production From Three Hubs to One
Green Queen · 9/24/2026Read original →
McDonald’s US Urged to Launch Vegan Burgers After Ranking Bottom of Plant-Forward List
Green Queen · 10/8/2026Read original →
Microalgae Grown from Cultivated Meat Waste Could Cut Costs for Cell-Cultured Proteins
Green Queen · 8/24/2026Read original →
MicroLub Bags $10M to Swap Fats with Water & Proteins Without Losing Flavour
Green Queen · 9/17/2026Read original →
MOA Foodtech Raises $3.8M to Expand AI-Led, Waste-Fermented Egg Substitute & Yeast Enhancer
Green Queen · 9/3/2026Read original →
Mother Pearl: Hong Kong’s Vegan Bubble Tea Brand Opens Wellness & Production Hub
Green Queen · 10/6/2026Read original →
Mushroom Squared Goes Beyond Plant-Based Meat to Offer Wellness-Minded Functional Proteins
Green Queen · 9/7/2026Read original →
Mycofeast Snaps Up NZ Precision-Fermented Dairy Protein Startup Daisy Lab
Green Queen · 10/15/2026Read original →
New Barn Organics Acquires Bam’s Buckwheat Milk Recipe to Fuel Regenerative Farming Push
Green Queen · 10/13/2026Read original →
New York City Expands Soy Milk Pilot in Schools After Cutting Food Emissions
Green Queen · 9/28/2026Read original →
New Zealand’s Boring Debuts High-Fibre Oat Milk Boosted with Yeast Protein
Green Queen · 10/1/2026Read original →
Newsom Signs Law to Create First-of-A-Kind Non-UPF Certified Label in California
Green Queen · 9/29/2026Read original →
NFL Alumni Partners With Sweet Protein Maker Oobli to Promote Healthier Sugar Alternatives
Green Queen · 9/10/2026Read original →
No Confusion: Nearly All Brits Know Plant-Based Products Don’t Contain Meat
Green Queen · 10/6/2026Read original →
No Country on Track to Meet Food System Emissions Goal for 2030, Shows UN-Backed Report
Green Queen · 9/28/2026Read original →
No Cow Updates Plant-Based Protein Bars with Fibre Focus & Improved Texture
Green Queen · 10/19/2026Read original →
NotCo Sells Brazilian Business & Reportedly Closes Mexican Arm Amid AI Pivot
Green Queen · 9/9/2026Read original →
Nourish Ingredients Signs European Manufacturing Deal to Scale Up Animal-Free Dairy Fat
Green Queen · 9/8/2026Read original →
Novel Food Firms Pausing UK Plans As EU Trade Deal Fuels Regulatory Uncertainty
Green Queen · 9/14/2026Read original →
Now Part of Refresco, SunOpta Opens $35M Production Line for Plant-Based Dairy
Green Queen · 9/24/2026Read original →
Oatly Calls on Food Industry to Remove Barriers to Sustainable Consumer Choices
Green Queen · 9/16/2026Read original →
Oatly Opens Immersive Matcha Pop-Up Ahead of London Fashion Week
Green Queen · 9/4/2026Read original →
Oatly’s New Packaging Spotlights Public Clamour for Governments to Tackle Climate Change
Green Queen · 8/31/2026Read original →
Onego Bio Brings Animal-Free Egg Protein to Breakfast Category with Zen Waffles
Green Queen · 9/10/2026Read original →
Op-Ed: Food Tech Commercialisation Shouldn’t Wait Until the Technical Answers Are In
Green Queen · 10/16/2026Read original →
Opinion: Blending Climate With Taste & Price Was A Win for Food at NYC Climate Week
Green Queen · 10/2/2026Read original →
OtherKinds: Koppie Unveils Consumer Brand for Pea-Based Beanless Coffee Drinks
Green Queen · 9/1/2026Read original →
Our Bodies Adapt to Plant-Based Diets Long-Term to Enhance Iron & Protein Uptake
Green Queen · 9/17/2026Read original →
Paleo Bags $2.3M to Advance Regulatory Filings for Animal-Free Meat Protein
Green Queen · 9/2/2026Read original →
Pinggu Consensus: China Bets on AI & Policy Coordination to Transform the Future of Food
Green Queen · 9/24/2026Read original →
Plant-Based Alternatives Now Up to 30% Cheaper Than Meat & Dairy in Dutch Supermarkets
Green Queen · 8/21/2026Read original →
Plant-Based Wellness Pioneer Organic Traditions Bags $10.5M to Plug North America’s Fibre Gap
Green Queen · 8/25/2026Read original →
Plenish Introduces Four-Ingredient Protein Oat Milk Fit for the UK’s Clean-Label Era
Green Queen · 9/3/2026Read original →
Researchers Tout ‘Self-Organising Tissues’ As Future of Cultivated Meat Production
Green Queen · 9/22/2026Read original →
Revo Foods Turns Apricot Kernels Into Protein-Packed Dairy-Free Cottage Cheese
Green Queen · 9/8/2026Read original →
Rosewood Hotels & Resorts to Expand Plant-Based Menu Options in Thailand
Green Queen · 8/21/2026Read original →
SaladStop Pledges to Source 60% of Protein from Plant-Based Food Globally
Green Queen · 8/28/2026Read original →
Scientists Are Using Darwinian Evolution & AI to Create Next-Gen Sustainable Proteins
Green Queen · 10/6/2026Read original →
Scottish Govt Pumps $3.3M Into MiAlgae’s Factory to Recycle Whisky Waste Into Algal Omega-3
Green Queen · 10/12/2026Read original →
Singapore Govt Reiterates Food Security Potential of Alternative Proteins
Green Queen · 9/25/2026Read original →
Singapore’s Shnëdz Brings Plant-Based Protein Bites to Meat-Reducing Malaysia
Green Queen · 10/1/2026Read original →
Soglowek Acquires 70% Stake in Thai Meat-Free Manufacturer Plant & Bean
Green Queen · 8/21/2026Read original →
Soufflet Malt, Eat the Truth Target Alternative Cocoa Flavours with Fermented Grains
Green Queen · 9/28/2026Read original →
Spain’s Elian Raises $46M From Govt Fund to Safeguard EU’s Plant Protein Sovereignty
Green Queen · 9/22/2026Read original →
Steakholder Foods Rolls Out 3D-Printed Whole-Cut Meat at US Supermarkets
Green Queen · 9/4/2026Read original →
Step Aside, Protein: Oatly Targets Europe’s Fibre Deficiency with Latest Oat Milk Range
Green Queen · 9/24/2026Read original →
Symplicity Centres Fermented Vegetables in Nut Roast As Brits Embrace Whole Foods
Green Queen · 9/11/2026Read original →
Symplicity Centres Fermented Vegetables in Plant-Based Roast As Brits Embrace Whole Foods
Green Queen · 9/11/2026Read original →
The Phytosphere: Why Beyond Meat Launched Plant-Based Protein Powders, Jerky & Veggie Burgers
Green Queen · 9/10/2026Read original →
This AI Toolkit Helps Food Companies Prove GRAS Status Faster Ahead of FDA Overhaul
Green Queen · 10/1/2026Read original →
This Hong Kong Future Lab Was Made Using Recycled Plastic Bottles
Green Queen · 9/4/2026Read original →
Those Vegan Cowboys Leads €1.2M Project to Make Sports Nutrition Products with Cow-Free Casein Protein
Green Queen · 9/28/2026Read original →
Time-Travelling Milkman Rebrands to TTM Ingredients As Next-Gen Sunflower Fat Expands Horizons
Green Queen · 8/24/2026Read original →
Tofu Named the ‘Best Source of Protein’ Across Health & Climate Metrics
Green Queen · 8/24/2026Read original →
Trade Body AMPS Partners with Cultigen Group to Advance Cultivated Meat Industry
Green Queen · 9/21/2026Read original →
Trump’s Beef Tariff Plan Protects the Largest Driver of Global Deforestation
Green Queen · 9/4/2026Read original →
UK FSA Issues Latest Guidance Documents for Cultivated Meat Approvals
Green Queen · 10/2/2026Read original →
UK Makes Beans Compulsory & Adds Fortified Pea Milk to School Food Menus
Green Queen · 9/15/2026Read original →
UK Scientists Use AI to Identify Nearly 800 Plant Proteins for Sustainable Food
Green Queen · 9/8/2026Read original →
UK Startup Omni Unveils Low-Carbon Functional Dog Food, Notches New Wholesale Listing
Green Queen · 10/2/2026Read original →
UK’s Gosh Expands Super Plants Line with High-Fibre Veggie Burgers
Green Queen · 9/25/2026Read original →
Ulrick + Short’s Sunflower Seed Flour Boosts Protein, Fibre & Texture Profile of Plant-Based Foods
Green Queen · 9/11/2026Read original →
UMass Amherst Launches $120M Future of Food Initiative Backed By State Funding
Green Queen · 9/22/2026Read original →
Upside Foods Withdraws $50M Bid to Buy Believer Meats’s US Facility, But Retains Interest
Green Queen · 8/26/2026Read original →
US Court Dismisses Onego Bio’s Animal-Free Egg IP Lawsuit Against The Every Company
Green Queen · 10/12/2026Read original →
US Vegan Seafood Maker Impact Food Winds Down As Meat-Eating Culture Persists
Green Queen · 8/31/2026Read original →
Veg-Led Food & Plant-Based Alternatives Can Coexist, Says Redefine Meat After Doubling UK Footprint
Green Queen · 9/8/2026Read original →
Voyage Foods Exits Retail to Boost Commercial Supply of Bean-Free Coffee, Chocolate & More
Green Queen · 9/14/2026Read original →
Wageningen University & Research Opens AI-Enabled Facility to Bring Future Foods to Market
Green Queen · 10/5/2026Read original →
Whitworths Debuts Unprocessed Walnut ‘Supermince’ in UK’s Largest Supermarket
Green Queen · 9/30/2026Read original →
WHO Partners with GFI APAC to Publish Public Health Report on Alternative Proteins
Green Queen · 10/14/2026Read original →
World Sustainability Organization Makes 30% Plant-Based Menus Mandatory for Restaurants
Green Queen · 10/5/2026Read original →
Yoga Bar Founder, Better Bite Ventures Launch $260,000 Scheme for Next-Gen Food Startups in India
Green Queen · 9/15/2026Read original →
Your Future Cookies Could Be Made from Upcycled Plastic Bottles
Green Queen · 8/25/2026Read original →“An open and collaborative culture”: what makes Sweden attractive for life sciences
Labiotech · 9/23/2026Read original →13 AI drug discovery companies you should know about
Labiotech · 10/16/2026Read original →15 biotech companies in China you should know about
Labiotech · 9/23/2026Read original →Amylin analogs in the clinic: a deep dive
Labiotech · 8/24/2026Read original →AstraZeneca’s pipeline strategy: building the next wave of growth
Labiotech · 9/22/2026Read original →B7-H3 ADCs: A new contender in small cell lung cancer and beyond
Labiotech · 10/19/2026Read original →Beyond biology: Nanobiotix’s physics-first approach to cancer
Labiotech · 8/21/2026Read original →Beyond Ozempic: the GLP-1 landscape in 2026
Labiotech · 9/14/2026Read original →BIO-Europe 2026: Expanding the scope at Europe’s leading biotech partnering event
Labiotech · 8/18/2026Read original →BIOSPAIN 2026: partnering, policy, and the rise of Spanish biotech
Labiotech · 8/28/2026Read original →BIOSPAIN 2026: Spain’s flagship biotech event is going annual
Labiotech · 9/15/2026Read original →BIOSPAIN 2026: The challenge of turning strong science into scale
Labiotech · 10/2/2026Read original →Bladder cancer treatment: where are we standing in 2026?
Labiotech · 9/2/2026Read original →Changing with the times: what is the future of biomarkers in neurology?
Labiotech · 9/30/2026Read original →Charcot-Marie-Tooth disease: can medicines make it past clinical trials?
Labiotech · 8/26/2026Read original →Could your microbial process be stronger? Uncovering opportunities before scale-up and commercialization
Labiotech · 8/25/2026Read original →Different clusters in different regions: what’s life sciences in Finland like?
Labiotech · 10/12/2026Read original →Eli Lilly’s pipeline in 2026: how the incretin boom is funding what comes next
Labiotech · 9/9/2026Read original →
ESC 2026: The drug development readouts that stood out
Labiotech · 9/1/2026Read original →From PCOS to PMOS: what does the therapeutic field look like right now?
Labiotech · 9/28/2026Read original →From strong science to mature companies: The next test for Spanish biotech
Labiotech · 10/7/2026Read original →Genomes to bioreactors: Saudi Arabia’s gene editing oncology push
Labiotech · 8/27/2026Read original →How AOCs are advancing targeted therapeutics
Labiotech · 8/31/2026Read original →How Evox Therapeutics is targeting CNS diseases with exosomes
Labiotech · 9/4/2026Read original →How Flagship’s Valo is reshaping AI drug discovery with human data
Labiotech · 10/2/2026Read original →How human-first datasets are reshaping AI drug discovery
Labiotech · 6/25/2026Read original →How macrocyclic drugs are gaining momentum in the cardiometabolic disease space
Labiotech · 9/30/2026Read original →How to choose lab consumables: A guide to sterility, performance, and sustainability
Labiotech · 10/13/2026Read original →How to navigate the IND process and shorten DNA-to-IND timelines to 6 months
Labiotech · 9/22/2026Read original →Inside Takeda’s transformation: The pipeline strategy behind its next growth chapter
Labiotech · 7/14/2026Read original →Investor confidence is built beyond the data
Labiotech · 9/1/2026Read original →Key considerations for adopting automated liquid handling platforms in pharmaceutical workflows
Labiotech · 9/29/2026Read original →Life science industry in Geneva on a roll
Labiotech · 8/19/2026Read original →Merck’s new BioReliance® Facility in Darmstadt: supporting biologics development and commercialization in Europe
Labiotech · 10/6/2026Read original →More options, better odds: the changing prostate cancer treatment landscape
Labiotech · 10/9/2026Read original →Navigating German biotech: 10 companies to keep an eye on in 2026
Labiotech · 9/15/2026Read original →New Graft-versus-Host Disease treatments: What’s in the biotech pipeline in 2026?
Labiotech · 9/25/2026Read original →New non-opioid pain medication: How is the biotech industry fighting pain after the opioid crisis?
Labiotech · 9/16/2026Read original →Nine biotech companies you should know about in Spain
Labiotech · 9/29/2026Read original →
NLS Days 2026: what’s dealmaking like in the Nordics?
Labiotech · 9/11/2026Read original →
Oncology biotech news: key moves to watch in September 2026
Labiotech · 9/16/2026Read original →Preclinical Pulse: The research catching our eye in October 2026
Labiotech · 10/14/2026Read original →Preclinical Pulse: The research catching our eye in September 2026
Labiotech · 9/9/2026Read original →Pushing biotech forward in France: 10 companies to know about
Labiotech · 10/13/2026Read original →Rethinking precision oncology drug development: AI and tumor biology for smarter therapeutic programs
Labiotech · 6/30/2026Read original →Rewriting the rules of genetic medicine with tRNA therapeutics
Labiotech · 9/11/2026Read original →Sanofi pipeline 2026: new leadership, same strategy?
Labiotech · 8/25/2026Read original →Saudi Arabia’s biotech momentum: inside RGMBS 2026
Labiotech · 10/9/2026Read original →Six MASH biotech companies shaping the future of liver disease treatment
Labiotech · 8/28/2026Read original →Streamlining stable cell line development from the start
Labiotech · 9/8/2026Read original →The best biotech conversations you missed this summer
Labiotech · 9/18/2026Read original →The biggest biotech funding rounds in August 2026
Labiotech · 9/2/2026Read original →The biggest biotech funding rounds in September 2026
Labiotech · 10/5/2026Read original →The cost of waiting: what licensing a biotech asset early really saves you
Labiotech · 8/21/2026Read original →The Metabolic Moment: 3 big bets to watch in metabolic disease
Labiotech · 10/14/2026Read original →The next big shake-up in the GLP-1 market? (Part 1 of 3)
Labiotech · 10/16/2026Read original →Theialife’s race to bring a childhood myopia treatment to market
Labiotech · 9/25/2026Read original →
Top biotech deals in August 2026
Labiotech · 9/4/2026Read original →
Top biotech deals in September 2026
Labiotech · 10/7/2026Read original →Unlocking cell & gene therapy performance: proven strategies for modern operations
Labiotech · 6/29/2026Read original →Viatris’s pipeline strategy: Moving beyond generics to find new growth
Labiotech · 10/6/2026Read original →
WCLC 2026: The lung cancer drug development readouts that caught our eye
Labiotech · 9/18/2026Read original →What can GLP-1s do beside treat diabetes and obesity?
Labiotech · 9/21/2026Read original →When every treatment counts: How clinical trials are changing the outlook for non-Hodgkin lymphoma patients
Labiotech · 9/7/2026Read original →
[Video] Mastering Channel Strategy: Thriving in a Complex, Competitive Market
New Hope · 9/2/2026Read original →
[Video] NBJ Practitioner Channel Data & Insights
New Hope · 9/4/2026Read original →
10 food and beverage brands using the natural colors consumers seek
New Hope · 10/3/2026Read original →
11 global flavors brands spicing up CPG
New Hope · 10/7/2026Read original →
11 standout finds from Newtopia Now
New Hope · 9/1/2026Read original →
5 iced coffees we're bringing to a job interview
New Hope · 10/20/2026Read original →
5 must-know trends that caught our editor's eye at Newtopia Now
New Hope · 8/31/2026Read original →
5 takeaways from Ulta Beauty's wellness strategy
New Hope · 9/11/2026Read original →
7 natural products brands pitch to investors at Newtopia Now
New Hope · 8/28/2026Read original →
9 brands proving the future of dairy is regenerative, traceable
New Hope · 10/5/2026Read original →
Access NBJ Summit sessions on market data, changes in channel sales
New Hope · 9/4/2026Read original →
AI chatbots start rewarding dietary supplements' quality over hype
New Hope · 9/17/2026Read original →
All eyes are on these 15 SupplySide Global exhibitors
New Hope · 10/17/2026Read original →
Analyst's Take: Why immunity supplements are reclaiming the wellness spotlight
New Hope · 9/11/2026Read original →
Analyst's Take: Why weight-loss supplements struggle to compete with GLP-1s despite strong consumer interest
New Hope · 10/1/2026Read original →
Announcing the 2026 Newtopia Now NEXTY Award finalists
New Hope · 8/26/2026Read original →
Ashwagandha's $1.5 billion market faces crisis as regulators clash over leaf versus root standards
New Hope · 9/24/2026Read original →
AWG Bakery expands into retail, aims beyond gluten-free shoppers
New Hope · 10/13/2026Read original →
BARI looks beyond fruit purées with Asian-inspired baby foods
New Hope · 8/27/2026Read original →
Barilla Group to acquire Goodles mac and cheese, strengthening both portfolios
New Hope · 9/4/2026Read original →
Big food and pharma bet billions on trusted supplement brands
New Hope · 10/12/2026Read original →
California creates state seal for non-ultraprocessed foods
New Hope · 9/30/2026Read original →
Chef, noted restaurateur Giada de Laurentiis shares her journey into CPG
New Hope · 8/26/2026Read original →
Chobani invests $1.2B in Allentown, Penn., to create high-protein milk
New Hope · 9/2/2026Read original →
Clio yogurt bar brand joins Chomps, Serenity Kids under Stride umbrella
New Hope · 10/15/2026Read original →
Closed: Applications to speak at Natural Products Expo West 2027
New Hope · 9/25/2026Read original →
Crave's sampling pop-ups drive brand loyalty among college students
New Hope · 9/25/2026Read original →
Cria Hair enters the menopause conversation with four ingredients and a wider mission
New Hope · 9/28/2026Read original →
Cutting Through the Noise - The Future of Functional Beverages & Brand Truth
New Hope · 10/1/2026Read original →
Danielle Calabrese looks at 6 forces reshaping food and beverage CPG
New Hope · 10/7/2026Read original →
Dee Charlemagne teaches brands how to get on Walmart shelves
New Hope · 8/28/2026Read original →
Dry Storage elevates at-home baking with regenerative, organic flour
New Hope · 8/20/2026Read original →
Editor's Take: The natural products industry's $363B milestone reveals a channel revolution in progress
New Hope · 9/2/2026Read original →
Editor’s Take: The supplement opportunity with prior GLP-1 users, particularly younger generations
New Hope · 10/9/2026Read original →
Ferrero Group acquires Purely Elizabeth for $850M to expand breakfast, wellness portfolio
New Hope · 8/25/2026Read original →
Functional beverage The Cycle wins Newtopia Now's wellness pitch competition
New Hope · 8/24/2026Read original →
Functional beverages for menstrual health fill gap on natural food shelves
New Hope · 9/29/2026Read original →
Gabby Reece's guide to an authentic life
New Hope · 8/25/2026Read original →
Hain Celestial to focus on North American brands, reducing debt after $323M sale
New Hope · 9/14/2026Read original →
How brands can fix hidden freight expenses that are quietly killing margins
New Hope · 8/27/2026Read original →
How independent retailers can avoid being an attractive target for online fraud
New Hope · 8/19/2026Read original →
How the manosphere is turning masculine anxiety into supplement sales
New Hope · 8/31/2026Read original →
How this plastic-free personal care brand tackles men's reproductive health
New Hope · 10/20/2026Read original →
How to make sense of the wall of shrooms
New Hope · 9/11/2026Read original →
Industry experts decode the big trends reshaping CPG
New Hope · 9/14/2026Read original →
Natural ingredients, clean-label certification drive health and beauty sales
New Hope · 9/7/2026Read original →
Nestle offloads Holistic Health platform for $1B
New Hope · 9/5/2026Read original →
Newtopia Now Connects 435+ Brands with Leading Retailers as Emerging CPG Innovation Takes Center Stage
New Hope · 8/27/2026Read original →
Newtopia Now embraces throwback trends honey, tea and bars
New Hope · 8/27/2026Read original →
Newtopia Now moves its 2027 chapter to Chicago
New Hope · 8/19/2026Read original →
Nominations open for 2027 Expo West NEXTY Awards until Dec. 2
New Hope · 10/2/2026Read original →
Nutrient data gives regenerative beef key to mainstream success
New Hope · 10/8/2026Read original →
OTA launches guide to USDA Organic for underserved handlers
New Hope · 10/15/2026Read original →
RMBR reshapes kombucha for the social scene
New Hope · 9/24/2026Read original →
Seed to Service event attendees donate 1,000 bags of produce to low-income families
New Hope · 9/15/2026Read original →
Skinimalism rules: Beauty brands win big with multifunctional dietary supplements
New Hope · 9/28/2026Read original →
SPINS launches agentic platform to help brands win the AI shelf
New Hope · 10/2/2026Read original →
State of Natural Industry Snapshot Fall 2026
New Hope · 8/28/2026Read original →
Supplement industry struggles to bring botanical supply chains back to U.S. soil
New Hope · 10/7/2026Read original →
Take a chance to win a free NEXTY Awards nomination
New Hope · 10/15/2026Read original →
Teddy's Tallow Chips taps into a hot trend
New Hope · 9/8/2026Read original →
The 3 ways U.S. supplement brands expand abroad—and when each one works
New Hope · 10/17/2026Read original →.png?disable=upscale&width=1200&height=630&fit=crop)
The Natural List: 10 takeaways from Organic Week 2026
New Hope · 9/30/2026Read original →.png?disable=upscale&width=1200&height=630&fit=crop)
The Natural List: Better for you beverages with GnuSante
New Hope · 9/26/2026Read original →
The Natural List: Jessica Rubino's favorite baby products; the surprising power of CPG ecosystems
New Hope · 9/2/2026Read original →
The Natural List: Narra co-founder brings Filipino flavors to RTD tea lattes
New Hope · 10/14/2026Read original →
The Natural List: New CPG trends from the Newtopia Now 2026 show floor
New Hope · 8/26/2026Read original →
The Natural List: New Hope editors go to town on the pumpkin spice aisle
New Hope · 10/7/2026Read original →.jpg?disable=upscale&width=1200&height=630&fit=crop)
The Natural List: Retail execution strategies for natural CPG brands
New Hope · 9/23/2026Read original →.jpg?disable=upscale&width=1200&height=630&fit=crop)
The Natural List: The peptide industry, explained
New Hope · 9/9/2026Read original →
The Natural List: Trust matters more than channel in retail strategy
New Hope · 9/16/2026Read original →
The NEXTY Awards return to Newtopia Now
New Hope · 8/24/2026Read original →
Tick-borne alpha-gal syndrome spreads fast, natural product solutions scarce
New Hope · 9/4/2026Read original →
Time for brands to move past the mycelium debate in functional mushrooms
New Hope · 9/10/2026Read original →
Unboxed: 13 essential pumpkin spice products for natural products enthusiasts
New Hope · 9/21/2026Read original →
What ashwagandha can teach brands about botanical transparency
New Hope · 10/7/2026Read original →.png?disable=upscale&width=1200&height=630&fit=crop)
What skincare brands need to know for long-term success in retail and e-commerce
New Hope · 9/22/2026Read original →.png?disable=upscale&width=1200&height=630&fit=crop)
What the Barilla x Goodles acquisition signals for the natural products industry
New Hope · 9/15/2026Read original →
What Whole Foods Market wants to see from emerging brands
New Hope · 10/6/2026Read original →.png?width=720&quality=80&disable=upscale)
Will the U.S. go cold turkey on Big Ag?
New Hope · 8/20/2026Read original →
“One-in-a-million” sea creature fossil preserves soft tissue for 450 million years
ScienceDaily · 8/21/2026Read original →
324-million-year-old fossil reveals how insects conquered land
ScienceDaily · 8/27/2026Read original →
A 24-year study uncovers a surprising climate benefit beneath forests
ScienceDaily · 10/17/2026Read original →
A broken rib from the world’s largest T. rex hid a 66-million-year-old secret
ScienceDaily · 9/24/2026Read original →
A fungus is threatening the world’s food supply. Scientists just found a new defense
ScienceDaily · 10/15/2026Read original →
A hidden “on switch” in human DNA has finally been decoded
ScienceDaily · 8/23/2026Read original →
A new way to fight gum disease without wiping out good bacteria
ScienceDaily · 10/7/2026Read original →
A simple touch can bring dying corals back to life in just 7 weeks
ScienceDaily · 10/19/2026Read original →Animals have been eating nature’s original bioplastic for millions of years
ScienceDaily · 8/17/2026Read original →
DNA recording system reveals how a single cell becomes a body
ScienceDaily · 10/13/2026Read original →
Don’t toss cannabis leaves: They may contain rare compounds with medical potential
ScienceDaily · 9/26/2026Read original →
Japanese scientists use tiny silver particles to make DNA assembly up to 5x more efficient
ScienceDaily · 8/19/2026Read original →
Life uses 4 DNA letters. Scientists just made 8 work
ScienceDaily · 9/5/2026Read original →
MIT turns bacteria into living transistors
ScienceDaily · 9/4/2026Read original →
Mulberry may reshape gut bacteria and influence metabolism
ScienceDaily · 9/30/2026Read original →
NASA finds Earth microbes could survive on the Moon
ScienceDaily · 8/25/2026Read original →
NASA-backed scientists turn plastic waste into edible cookies
ScienceDaily · 9/13/2026Read original →
New soil test could reveal how soil microbes help feed plants
ScienceDaily · 9/27/2026Read original →
One tiny chemical difference between RNA and DNA may help explain how life began
ScienceDaily · 10/2/2026Read original →
Pollen has a surprising problem — and honeybees have found a way around it
ScienceDaily · 8/19/2026Read original →
Queen bees have a disturbing way to survive pesticides
ScienceDaily · 8/22/2026Read original →
Researchers unveil sustainable spirulina solution to vitamin B12 deficiency
ScienceDaily · 8/30/2026Read original →
Scientists accidentally discover a genetic code that breaks the rules of life
ScienceDaily · 10/8/2026Read original →
Scientists discover a hidden “ID card” in cat urine
ScienceDaily · 9/20/2026Read original →
Scientists discover a human brain gene that can jump through DNA
ScienceDaily · 10/5/2026Read original →
Scientists discover a plastic-eating “Pac-Man” enzyme with a surprising secret
ScienceDaily · 10/16/2026Read original →
Scientists discover a powerful new antivenom hidden in rattlesnake blood
ScienceDaily · 9/8/2026Read original →
Scientists discover first new penguin species in more than 100 years
ScienceDaily · 9/22/2026Read original →
Scientists discover why a 100-year-old mushroom disease won't go away
ScienceDaily · 10/12/2026Read original →
Scientists finally see DNA “zip” itself together for the first time
ScienceDaily · 9/10/2026Read original →
Scientists find a surprising genetic twist behind octopus intelligence
ScienceDaily · 10/13/2026Read original →
Scientists find new virus behind mysterious tick illness
ScienceDaily · 9/29/2026Read original →
Scientists reveal what seven days of fasting does to the human body
ScienceDaily · 10/5/2026Read original →
Scientists say house cats could help unlock better cancer treatments for humans
ScienceDaily · 9/27/2026Read original →
Stanford scientists discover a seafood that can reverse signs of aging
ScienceDaily · 9/4/2026Read original →
Stanford’s new microscope reveals living cells like never before
ScienceDaily · 10/17/2026Read original →
The “glue” holding your cells together has a surprising second job
ScienceDaily · 10/5/2026Read original →
The secret to growing food on Mars could be fungi
ScienceDaily · 9/26/2026Read original →
The secret to longer life may be hidden in bat DNA
ScienceDaily · 9/12/2026Read original →
This deep-sea enzyme survives heat that destroys most proteins
ScienceDaily · 9/19/2026Read original →